ý
|
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
For the fiscal year ended December 31, 2016
|
|
OR
|
|
o
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
For the transition period from to
|
|
Commission File No. 001-35517
|
Maryland
|
|
45-3148087
|
(State or other jurisdiction of
incorporation or organization)
|
|
(I.R.S. Employer
Identification No.)
|
245 Park Avenue, 42nd Floor, New York, NY 10167
(Address of principal executive offices) (Zip Code)
|
||
(212) 750-7300
(Registrant's telephone number, including area code)
|
Title of each class
|
|
Name of each exchange on which registered
|
Common Stock, $0.01 par value per share
|
|
New York Stock Exchange
|
Large accelerated filer
o
|
|
Accelerated filer
ý
|
|
Non-accelerated filer
o
(Do not check if a smaller
reporting company)
|
|
Smaller reporting company
o
|
|
Page
|
|
|
|
|
|
|
|
|
|
•
|
Senior Mortgage Loans:
These mortgage loans are typically secured by first liens on commercial properties, including the following property types: office, multifamily, self-storage, retail, hotel, healthcare, student housing, industrial and mixed-use. In some cases, first lien mortgages may be divided into an A-Note and a B-Note. The A-Note is typically a privately negotiated loan that is secured by a first mortgage on a commercial property or group of related properties that is senior to a B-Note secured by the same first mortgage property or group.
|
•
|
Subordinated Debt:
These loans may include structurally subordinated first mortgage loans and junior participations in first mortgage loans or participations in these types of assets. As noted above, a B-Note is typically a privately negotiated loan that is secured by a first mortgage on a commercial property or group of related properties and is subordinated to an A-Note secured by the same first mortgage property or group. The subordination of a B-Note or junior participation typically is evidenced by participations or intercreditor agreements with other holders of interests in the note. B-Notes are subject to more credit risk with respect to the underlying mortgage collateral than the corresponding A-Note.
|
•
|
Preferred Equity:
Real estate preferred equity investments are subordinate to first mortgage loans and are not collateralized by the property underlying the investment. As a holder of preferred equity, we seek to enhance our position with covenants that limit the activities of the entity in which we have an interest and protect our equity by obtaining an exclusive right to control the underlying property after an event of default, should such a default occur on our investment.
|
•
|
Mezzanine Loans:
Like B‑Notes, these loans are also subordinated CRE loans, but are usually secured by a pledge of the borrower’s equity ownership in the entity that owns the property or by a second lien mortgage on the property. In a liquidation, these loans are generally junior to any mortgage liens on the underlying property, but senior to any preferred equity or common equity interests in the entity that owns the property. Investor rights are usually governed by intercreditor agreements.
|
•
|
Other CRE Investments:
To a lesser extent, we may invest in other loans and securities, subject to maintaining our qualification as a REIT, including but not limited to commercial mortgage-backed securities, loans to real estate or hospitality companies, debtor-in-possession loans and selected other income producing equity investments, such as triple net lease equity.
|
•
|
our cash flow from operations may be insufficient to make required payments of principal of and interest on the debt or we may fail to comply with all of the other covenants contained in the debt, which is likely to result in (a) acceleration of such debt (and any other debt containing a cross-default or cross-acceleration provision) that we may be unable to repay from internal funds or to refinance on favorable terms, or at all, (b) our inability to borrow unused amounts under our financing arrangements, even if we are current in
|
•
|
our debt may increase our vulnerability to adverse economic and industry conditions with no assurance that investment yields will increase with higher financing costs;
|
•
|
we may be required to dedicate a substantial portion of our cash flow from operations to payments on our debt, thereby reducing funds available for operations, future business opportunities, stockholder distributions or other purposes;
|
•
|
we are not able to refinance debt that matures prior to the investment it was used to finance on favorable terms, or at all; and
|
•
|
as the holder of the subordinated classes of the two securitizations, we may be required to absorb losses
|
•
|
general economic or market conditions;
|
•
|
the market's view of the quality of our assets;
|
•
|
the market's perception of our growth potential;
|
•
|
our current and potential future earnings and cash distributions; and
|
•
|
the market price of the shares of our common stock.
|
•
|
interest rate hedging can be expensive, particularly during periods of rising and volatile interest rates;
|
•
|
available interest rate hedges may not correspond directly with the interest rate risk for which protection is sought;
|
•
|
due to a credit loss, the duration of the hedge may not match the duration of the related liability;
|
•
|
the amount of income that a REIT may earn from hedging transactions (other than hedging transactions that satisfy certain requirements of the Code or that are done through a TRS) to offset interest rate losses is limited by U.S. federal income tax provisions governing REITs;
|
•
|
the credit quality of the hedging counterparty owing money on the hedge may be downgraded to such an extent that it impairs our ability to sell or assign our side of the hedging transaction; and
|
•
|
the hedging counterparty owing money in the hedging transaction may default on its obligation to pay.
|
•
|
acts of God, including earthquakes, floods and other natural disasters, which may result in uninsured losses;
|
•
|
acts of war or terrorism, including the consequences of terrorist attacks;
|
•
|
adverse changes in national and local economic and market conditions, including local markets with a significant exposure to the energy sector, which may be affected by the current low prices of oil and related gas that could adversely affect the success of tenants in that industry;
|
•
|
changes in governmental laws and regulations (including their interpretations), fiscal policies and zoning ordinances and the related costs of compliance with laws and regulations, fiscal policies and ordinances;
|
•
|
costs of remediation and liabilities associated with environmental conditions such as indoor mold; and
|
•
|
the potential for uninsured or under-insured property losses.
|
•
|
tenant mix;
|
•
|
success of tenant businesses;
|
•
|
property management decisions;
|
•
|
property location, condition and design;
|
•
|
competition from comparable types of properties;
|
•
|
changes in laws that increase operating expenses or limit rents that may be charged;
|
•
|
changes in national, regional or local economic conditions and/or specific industry segments, including the credit and securitization markets;
|
•
|
declines in regional or local real estate values;
|
•
|
changes in local markets in which our tenants operate, including changes in oil and gas prices;
|
•
|
declines in regional or local rental or occupancy rates;
|
•
|
increases in interest rates, real estate tax rates and other operating expenses;
|
•
|
costs of remediation and liabilities associated with environmental conditions;
|
•
|
the potential for uninsured or underinsured property losses;
|
•
|
changes in governmental laws and regulations, including fiscal policies, zoning ordinances and environmental legislation and the related costs of compliance; and
|
•
|
acts of God, terrorist attacks, social unrest and civil disturbances.
|
•
|
our actual or projected operating results, financial condition, cash flows and liquidity, or changes in business strategy or prospects;
|
•
|
actual or perceived conflicts of interest with our Manager or Ares Management and individuals, including our executives;
|
•
|
equity issuances by us, or share resales by our stockholders, or the perception that such issuances or resales may occur;
|
•
|
loss of a major funding source;
|
•
|
actual or anticipated accounting problems;
|
•
|
publication of research reports about us or the real estate industry;
|
•
|
changes in market valuations of similar companies;
|
•
|
adverse market reaction to any increased indebtedness we incur in the future;
|
•
|
additions to or departures of our Manager's or Ares Management's key personnel;
|
•
|
speculation in the press or investment community;
|
•
|
increases in market interest rates, which may lead investors to demand a higher distribution yield for our common stock and would result in increased interest expenses on our debt;
|
•
|
failure to maintain our REIT qualification or exemption from the 1940 Act;
|
•
|
price and volume fluctuations in the overall stock market from time to time;
|
•
|
general market and economic conditions, and trends including inflationary concerns, the current state of the credit and capital markets;
|
•
|
significant volatility in the market price and trading volume of securities of publicly traded REITs or other companies in our sector, which are not necessarily related to the operating performance of these companies;
|
•
|
changes in law, regulatory policies or tax guidelines, or interpretations thereof, particularly with respect to REITs;
|
•
|
changes in the value of our portfolio;
|
•
|
any shortfall in revenue or net income or any increase in losses from levels expected by investors or securities analysts;
|
•
|
operating performance of companies comparable to us;
|
•
|
short-selling pressure with respect to shares of our common stock or REITs generally;
|
•
|
uncertainty surrounding the strength of the U.S. economic recovery particularly in light of the downgrade of the U.S. Government's credit rating;
|
•
|
concerns regarding European sovereign debt; and
|
•
|
concerns regarding volatility in the Chinese stock market and currency.
|
•
|
our ability to make profitable investments;
|
•
|
margin calls or other expenses that reduce our cash flow;
|
•
|
defaults in our asset portfolio or decreases in the value of our portfolio; and
|
•
|
the fact that anticipated operating expense levels may not prove accurate, as actual results may vary from estimates.
|
•
|
80% of the votes entitled to be cast by holders of the then-outstanding shares of voting stock of the corporation; and
|
•
|
two-thirds of the votes entitled to be cast by holders of voting stock of the corporation, other than shares held by the interested stockholder with whom or with whose affiliate the business combination is to be effected, or held by an affiliate or associate of the interested stockholder.
|
•
|
the election or removal of directors;
|
•
|
the amendment of our charter, except that our board of directors may amend our charter without stockholder approval to:
|
•
|
change our name;
|
•
|
change the name or other designation or the par value of any class or series of stock and the aggregate par value of our stock;
|
•
|
increase or decrease the aggregate number of shares of stock that we have the authority to issue;
|
•
|
increase or decrease the number of shares of any class or series of stock that we have the authority to issue; and
|
•
|
effect certain reverse stock splits;
|
•
|
our liquidation and dissolution; and
|
•
|
our being a party to a merger, consolidation, sale or other disposition of all or substantially all of our assets or statutory share exchange.
|
|
High
|
|
Low
|
|
Cash Dividends Declared
Per Share of Common Stock |
|
||||||
Year ended December 31, 2016
|
|
|
|
|
|
|
|
|
|
|||
First quarter
|
$
|
11.83
|
|
|
$
|
9.02
|
|
|
$
|
0.26
|
|
(1)
|
Second quarter
|
$
|
12.42
|
|
|
$
|
10.97
|
|
|
$
|
0.26
|
|
(2)
|
Third quarter
|
$
|
13.00
|
|
|
$
|
12.18
|
|
|
$
|
0.26
|
|
(3)
|
Fourth quarter
|
$
|
14.27
|
|
|
$
|
12.45
|
|
|
$
|
0.26
|
|
(4)
|
|
High
|
|
Low
|
|
Cash Dividends Declared
Per Share of Common Stock |
|
||||||
Year ended December 31, 2015
|
|
|
|
|
|
|
|
|
|
|||
First quarter
|
$
|
12.35
|
|
|
$
|
11.05
|
|
|
$
|
0.25
|
|
(5)
|
Second quarter
|
$
|
11.91
|
|
|
$
|
11.02
|
|
|
$
|
0.25
|
|
(6)
|
Third quarter
|
$
|
13.08
|
|
|
$
|
11.41
|
|
|
$
|
0.25
|
|
(7)
|
Fourth quarter
|
$
|
13.00
|
|
|
$
|
11.44
|
|
|
$
|
0.25
|
|
(8)
|
(1)
|
On
March 1, 2016
, we declared a cash dividend of
$0.26
per common share of our common stock, payable on
April 15, 2016
to our common stockholders of record as of
March 31, 2016
.
|
(2)
|
On
May 5, 2016
, we declared a cash dividend of
$0.26
per share of our common stock, payable on
July 15, 2016
to our common stockholders of record as of
June 30, 2016
.
|
(3)
|
On
August 4, 2016
, we declared a cash dividend of
$0.26
per share of our common stock, payable on
October 17, 2016
to our common stockholders of record as of
September 30, 2016
.
|
(4)
|
On
November 3, 2016
, we declared a cash dividend of
$0.26
per share of our common stock, payable on
January 17, 2017
to our common stockholders of record as of
December 30, 2016
.
|
(5)
|
On
March 5, 2015
, we declared a cash dividend of
$0.25
per common share of our common stock, payable on
April 15, 2015
to our common stockholders of record as of
March 31, 2015
.
|
(6)
|
On
May 7, 2015
, we declared a cash dividend of
$0.25
per share of our common stock, payable on
July 15, 2015
to our common stockholders of record as of
June 30, 2015
.
|
(7)
|
On
July 30, 2015
, we declared a cash dividend of
$0.25
per share of our common stock, payable on
October 15, 2015
to our common stockholders of record as of
September 30, 2015
.
|
(8)
|
On
November 5, 2015
, we declared a cash dividend of
$0.25
per share of our common stock, payable on
January 19, 2016
to our common stockholders of record as of
December 31, 2015
.
|
Period
|
|
Total Number of Shares Purchased
|
|
Average Price Paid Per Share (1)
|
|
Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs
|
|
Maximum (or Approximate Dollar Value) of Shares that May Yet Be Purchased Under the Plans or Programs (in thousands)
|
||||||
January 1, 2016 through January 31, 2016
|
|
—
|
|
|
—
|
|
|
—
|
|
|
$
|
20,000
|
|
|
February 1, 2016 through February 29, 2016
|
|
—
|
|
|
—
|
|
|
—
|
|
|
$
|
30,000
|
|
|
March 1, 2016 through March 31, 2016
|
|
34,854
|
|
|
$
|
10.28
|
|
|
34,854
|
|
|
$
|
29,642
|
|
April 1, 2016 through April 30, 2016
|
|
95,062
|
|
|
$
|
11.34
|
|
|
95,062
|
|
|
$
|
28,563
|
|
May 1, 2016 through May 31, 2016
|
|
—
|
|
|
—
|
|
|
—
|
|
|
$
|
28,563
|
|
|
June 1, 2016 through June 30, 2016
|
|
—
|
|
|
—
|
|
|
—
|
|
|
$
|
28,563
|
|
|
July 1, 2016 through July 31, 2016
|
|
—
|
|
|
—
|
|
|
—
|
|
|
$
|
28,563
|
|
|
August 1, 2016 through August 31, 2016
|
|
—
|
|
|
—
|
|
|
—
|
|
|
$
|
28,563
|
|
|
September 1, 2016 through September 30, 2016
|
|
—
|
|
|
—
|
|
|
—
|
|
|
$
|
28,563
|
|
|
October 1, 2016 through October 31, 2016
|
|
—
|
|
|
—
|
|
|
—
|
|
|
$
|
28,563
|
|
|
November 1, 2016 through November 30, 2016
|
|
—
|
|
|
—
|
|
|
—
|
|
|
$
|
28,563
|
|
|
December 1, 2016 through December 31, 2016
|
|
—
|
|
|
—
|
|
|
—
|
|
|
$
|
28,563
|
|
|
Total
|
|
129,916
|
|
|
$
|
11.06
|
|
|
129,916
|
|
|
|
(1)
|
Amount includes expenses paid.
|
SOURCE:
|
SNL Financial LC and Standard & Poor's Institutional Services
|
NOTES:
|
Assumes $100 invested on April 26, 2012 (the date ACRE's shares began trading in connection with the IPO) in ACRE, the S&P 500 Index and the SNL US Finance REIT. Assumes all dividends are reinvested on the respective dividend payment dates without commissions.
|
|
4/26/12
|
|
12/31/12
|
|
12/31/13
|
|
12/31/14
|
|
12/31/15
|
|
12/31/16
|
||||||
ACRE
|
100.00
|
|
|
91.88
|
|
|
78.51
|
|
|
74.41
|
|
|
80.55
|
|
|
105.39
|
|
S&P 500 Index
|
100.00
|
|
|
103.54
|
|
|
137.07
|
|
|
155.83
|
|
|
157.99
|
|
|
176.89
|
|
SNL US Finance REIT
|
100.00
|
|
|
106.89
|
|
|
103.24
|
|
|
118.23
|
|
|
108.41
|
|
|
133.54
|
|
Plan Category
|
|
Number of
securities to be issued upon exercise of outstanding options, warrants and rights |
|
Weighted-
average exercise price of outstanding options, warrants and rights |
|
Number of
securities remaining available for future issuance under equity compensation plans (excluding securities reflected in the first column of this table)(1) |
||||
Equity compensation plans approved by stockholders
|
|
—
|
|
|
$
|
—
|
|
|
467,153
|
|
Equity compensation plans not approved by stockholders
|
|
—
|
|
|
—
|
|
|
—
|
|
|
Total
|
|
—
|
|
|
$
|
—
|
|
|
467,153
|
|
(1)
|
The securities shown in this column may be issued as restricted stock, restricted stock units and/or other equity-based awards to eligible awardees under our 2012 Equity Incentive Plan.
|
|
For the year ended December 31,
|
|
||||||||||||||||||
|
2016
|
|
2015
|
|
2014
|
|
2013
|
|
2012
|
|
||||||||||
Operating Data:
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Net interest margin, excluding non-controlling interests held by third parties
|
$
|
40,568
|
|
|
$
|
40,936
|
|
|
$
|
36,551
|
|
|
$
|
22,627
|
|
|
$
|
6,720
|
|
|
Gain on sale of loans
|
—
|
|
|
—
|
|
|
680
|
|
|
—
|
|
|
—
|
|
|
|||||
Total expenses
|
14,426
|
|
|
13,671
|
|
|
14,549
|
|
|
16,475
|
|
|
5,763
|
|
|
|||||
Net income from continuing operations
|
30,451
|
|
|
36,335
|
|
|
22,749
|
|
|
12,329
|
|
|
860
|
|
|
|||||
Net income from operations of discontinued operations, net of income taxes
|
4,221
|
|
|
6,985
|
|
|
1,867
|
|
|
1,437
|
|
|
—
|
|
|
|||||
Gain on sale of discontinued operations
|
10,196
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
|||||
Net income attributable to common stockholders
|
40,336
|
|
|
34,285
|
|
|
24,396
|
|
|
13,766
|
|
|
186
|
|
|
|||||
Basic weighted average shares of common stock outstanding
|
28,461,853
|
|
|
28,501,897
|
|
|
28,459,309
|
|
|
18,989,500
|
|
|
6,532,706
|
|
|
|||||
Diluted weighted average shares of common stock outstanding
|
28,523,306
|
|
|
28,597,568
|
|
|
28,585,022
|
|
|
19,038,152
|
|
|
6,567,309
|
|
|
|||||
Basic earnings per common share:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||
Continuing operations
|
$
|
0.91
|
|
|
$
|
0.96
|
|
|
$
|
0.79
|
|
|
$
|
0.65
|
|
|
$
|
0.03
|
|
|
Discontinued operations
|
0.51
|
|
|
0.25
|
|
|
0.07
|
|
|
0.08
|
|
|
—
|
|
|
|||||
Net income
|
$
|
1.42
|
|
|
$
|
1.20
|
|
|
$
|
0.86
|
|
|
$
|
0.72
|
|
|
$
|
0.03
|
|
|
Diluted earnings per common share:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||
Continuing operations
|
$
|
0.91
|
|
|
$
|
0.95
|
|
|
$
|
0.79
|
|
|
$
|
0.65
|
|
|
$
|
0.03
|
|
|
Discontinued operations
|
0.51
|
|
|
0.24
|
|
|
0.07
|
|
|
0.08
|
|
|
—
|
|
|
|||||
Net income
|
$
|
1.41
|
|
|
$
|
1.20
|
|
|
$
|
0.85
|
|
|
$
|
0.72
|
|
|
$
|
0.03
|
|
|
Dividends declared per share of common stock
|
$
|
1.04
|
|
|
$
|
1.00
|
|
|
$
|
1.00
|
|
|
$
|
1.00
|
|
|
$
|
0.67
|
|
(1)
|
Balance Sheet Data:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||
Loans held for investment
|
1,313,937
|
|
|
1,174,391
|
|
|
1,462,584
|
|
|
958,495
|
|
|
353,500
|
|
|
|||||
Total assets
|
1,373,703
|
|
|
1,378,982
|
|
|
1,862,155
|
|
|
1,169,606
|
|
|
385,111
|
|
|
|||||
Secured funding agreements
|
780,713
|
|
|
522,775
|
|
|
552,799
|
|
|
264,419
|
|
|
144,256
|
|
|
|||||
Secured term loan
|
149,878
|
|
|
69,762
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
|||||
Total unsecured debt
|
—
|
|
|
—
|
|
|
67,414
|
|
|
65,893
|
|
|
64,541
|
|
|
|||||
Total securitizations debt
|
—
|
|
|
254,343
|
|
|
523,229
|
|
|
389,640
|
|
|
—
|
|
|
|||||
Total liabilities
|
944,030
|
|
|
922,494
|
|
|
1,381,269
|
|
|
763,390
|
|
|
219,673
|
|
|
|||||
Total stockholders' equity
|
419,029
|
|
|
409,471
|
|
|
402,954
|
|
|
406,216
|
|
|
165,438
|
|
|
|||||
Total equity
|
429,673
|
|
|
456,488
|
|
|
480,886
|
|
|
406,216
|
|
|
165,438
|
|
|
•
|
ACRE originated a $56.0 million senior mortgage loan on a hotel portfolio located in California.
|
•
|
ACRE originated a $25.5 million senior mortgage loan on an office property located in Kansas.
|
•
|
ACRE originated a $17.0 million mezzanine loan on an office property located in New Jersey.
|
•
|
ACRE amended its $50.0 million Bridge Loan Warehousing Credit and Security Agreement (the “BAML Facility”) with Bank of America, N.A. to expand the eligible assets to include loans secured by general and affordable multifamily properties.
|
•
|
ACRE amended its $50.0 million secured revolving funding facility (the “March 2014 CNB Facility”) with City National Bank to extend the maturity date to March 11, 2017.
|
•
|
ACRE originated a $76.0 million senior mortgage loan on a mixed-use property located in New York.
|
•
|
ACRE originated a $15.2 million senior mortgage loan on an office property located in California.
|
•
|
ACRE entered into an agreement to sell TRS Holdings, the holding company that owns ACRE Capital, to
|
•
|
The commercial mortgage-backed securities securitization was terminated on June 17, 2016.
|
•
|
ACRE amended the master repurchase funding facility with Wells Fargo Bank, National Association (“Wells Fargo”) (as amended and restated, the “Wells Fargo Facility”) to, among other things, increase the size of the facility from $225.0 million to $325.0 million and extend the initial maturity date to December 14, 2017.
|
•
|
The global master repurchase agreement with UBS AG (the “December 2014 UBS Facility") was repaid in full.
|
•
|
ACRE amended the BAML Facility to extend the initial maturity date to May 25, 2017 and the final maturity date to May 25, 2020.
|
•
|
ACRE originated a $159.2 million senior mortgage loan collateralized by a portfolio of assets comprised of self-storage, retail and office properties across a multi-state area.
|
•
|
ACRE originated a $99.0 million senior mortgage loan collateralized by a portfolio of assets comprised of self-storage and retail properties across a multi-state area.
|
•
|
ACRE originated a $89.7 million senior mortgage loan on a multifamily property located in Florida.
|
•
|
ACRE originated a $72.0 million senior mortgage loan on an office property located in Illinois.
|
•
|
ACRE originated a $62.5 million senior mortgage loan on an office property located in California.
|
•
|
ACRE originated a $45.4 million senior mortgage loan on a multifamily property located in Florida.
|
•
|
ACRE originated a $34.1 million senior mortgage loan on a multifamily property located in Minnesota.
|
•
|
ACRE originated a $23.3 million senior mortgage loan on a multifamily property located in Florida.
|
•
|
ACRE originated a $20.1 million senior mortgage loan on an office property located in Pennsylvania.
|
•
|
ACRE amended its $250.0 million master repurchase facility (the “Citibank Facility”) with Citibank, N.A., which added an accordion feature that provides for an increase in the $250.0 million commitment amount with respect to approved assets, as determined by Citibank, N.A. in its sole discretion.
|
•
|
ACRE amended and restated the BAML Facility to increase its commitment size from $50.0 million to $125.0 million.
|
•
|
ACRE repaid in full its $75.0 million revolving funding facility (the “July 2014 CNB Facility”) with City National Bank and its terms were not extended.
|
•
|
ACRE entered into a $125.0 million master repurchase and securities contract (the "U.S. Bank Facility") with
|
•
|
ACRE drew the remaining $80.0 million commitment under the Credit and Guaranty Agreement (the ‘‘Secured Term Loan”) with Highbridge Principal Strategies, LLC, as administrative agent, and DBD Credit Funding LLC, as collateral agent.
|
•
|
ACRE closed the ACRE Capital Sale.
|
•
|
ACRE originated a loan on an office property located in Texas, comprised of a $70.1 million senior mortgage loan and a $10.3 million B-Note mortgage loan.
|
•
|
The collateralized loan obligation ("CLO") securitization was terminated on December 16, 2016.
|
•
|
ACRE amended its Citibank Facility to extend the initial maturity date to December 10, 2018. Additionally, new advances under the Citibank Facility after December 8, 2016 accrue interest at a per annum rate equal to
one-month LIBOR
plus a pricing margin range of
2.25%
to
2.50%
, subject to certain exceptions.
|
•
|
the interest expense associated with our borrowings to increase, subject to any applicable ceilings;
|
•
|
the value of our mortgage loans to decline;
|
•
|
coupons on our floating rate mortgage loans to reset to higher interest rates; and
|
•
|
to the extent we enter into interest rate swap agreements as part of our hedging strategy where we pay fixed and receive floating interest rates, the value of these agreements to increase.
|
•
|
the interest expense associated with our borrowings to decrease, subject to any applicable floors;
|
•
|
the value of our mortgage loan portfolio to increase, for such mortgages with applicable floors;
|
•
|
coupons on our floating rate mortgage loans to reset to lower interest rates; and
|
•
|
to the extent we enter into interest rate swap agreements as part of our hedging strategy where we pay fixed and receive floating interest rates, the value of these agreements to decrease.
|
|
As of December 31, 2016
|
||||||||||||||
|
Carrying Amount (1)
|
|
Outstanding Principal (1)
|
|
Weighted Average Interest Rate
|
|
Weighted Average Unleveraged Effective Yield (2)
|
|
Weighted Average Remaining Life (Years)
|
||||||
Senior mortgage loans
|
$
|
1,181,569
|
|
|
$
|
1,188,425
|
|
|
4.7
|
%
|
|
5.7
|
%
|
|
1.8
|
Subordinated debt and preferred equity investments
|
121,828
|
|
|
123,230
|
|
|
10.7
|
%
|
|
11.5
|
%
|
|
4.1
|
||
Total loans held for investment portfolio (excluding non-controlling interests held by third parties)
|
$
|
1,303,397
|
|
|
$
|
1,311,655
|
|
|
5.2
|
%
|
|
6.3
|
%
|
|
2.0
|
(1)
|
The difference between the Carrying Amount and the Outstanding Principal face amount of the loans held for investment consists of unamortized purchase discount, deferred loan fees and loan origination costs.
|
(2)
|
Unleveraged Effective Yield is the compounded effective rate of return that would be earned over the life of the investment based on the contractual interest rate (adjusted for any deferred loan fees, costs, premium or discount) and assumes no dispositions, early prepayments or defaults. The Total Weighted Average Unleveraged Effective Yield is calculated based on the average of Unleveraged Effective Yield of all loans held by us as of
December 31, 2016
as weighted by the Outstanding Principal balance of each loan.
|
|
As of December 31, 2016
|
||||||
|
Carrying Amount
|
|
Outstanding Principal
|
||||
Total loans held for investment portfolio (excluding non-controlling interests held by third parties)
|
$
|
1,303,397
|
|
|
$
|
1,311,655
|
|
Non-controlling interest investment held by third parties
|
10,540
|
|
|
10,540
|
|
||
Loans held for investment
|
$
|
1,313,937
|
|
|
$
|
1,322,195
|
|
|
For the year ended December 31, 2016
|
||
Interest income from loans held for investment, excluding non-controlling interests
|
$
|
77,424
|
|
Interest income from non-controlling interest investment held by third parties
|
4,539
|
|
|
Interest income from loans held for investment
|
$
|
81,963
|
|
|
For the years ended December 31,
|
||||||||||
|
2016
|
|
2015
|
|
2014
|
||||||
Net interest margin
|
$
|
45,107
|
|
|
$
|
49,995
|
|
|
$
|
36,858
|
|
Gain on sale of loans
|
—
|
|
|
—
|
|
|
680
|
|
|||
Total expenses
|
14,426
|
|
|
13,671
|
|
|
14,549
|
|
|||
Income from continuing operations before income taxes
|
30,681
|
|
|
36,324
|
|
|
22,989
|
|
|||
Income tax expense (benefit), including excise tax
|
230
|
|
|
(11
|
)
|
|
240
|
|
|||
Net income from continuing operations
|
30,451
|
|
|
36,335
|
|
|
22,749
|
|
|||
Net income from operations of discontinued operations, net of income taxes
|
4,221
|
|
|
6,985
|
|
|
1,867
|
|
|||
Gain on sale of discontinued operations
|
10,196
|
|
|
—
|
|
|
—
|
|
|||
Net income attributable to ACRE
|
44,868
|
|
|
43,320
|
|
|
24,616
|
|
|||
Less: Net income attributable to non-controlling interests
|
(4,532
|
)
|
|
(9,035
|
)
|
|
(220
|
)
|
|||
Net income attributable to common stockholders
|
$
|
40,336
|
|
|
$
|
34,285
|
|
|
$
|
24,396
|
|
|
For the years ended December 31,
|
||||||||||
|
2016
|
|
2015
|
|
2014
|
||||||
Interest income from loans held for investment
|
$
|
81,963
|
|
|
$
|
86,337
|
|
|
$
|
70,495
|
|
Interest expense
|
(36,856
|
)
|
|
(36,342
|
)
|
|
(33,637
|
)
|
|||
Net interest margin
|
$
|
45,107
|
|
|
$
|
49,995
|
|
|
$
|
36,858
|
|
|
For the years ended December 31,
|
||||||||||
|
2016
|
|
2015
|
|
2014
|
||||||
Management and incentive fees to affiliate
|
$
|
5,956
|
|
|
$
|
5,397
|
|
|
$
|
5,440
|
|
Professional fees
|
2,228
|
|
|
2,018
|
|
|
2,686
|
|
|||
Acquisition and investment pursuit costs
|
—
|
|
|
—
|
|
|
20
|
|
|||
General and administrative expenses
|
2,801
|
|
|
2,830
|
|
|
3,003
|
|
|||
General and administrative expenses reimbursed to affiliate
|
3,441
|
|
|
3,426
|
|
|
3,400
|
|
|||
Total expenses
|
$
|
14,426
|
|
|
$
|
13,671
|
|
|
$
|
14,549
|
|
|
For the years ended December 31,
|
||||||||||
|
2016
|
|
2015
|
|
2014
|
||||||
Net income
|
$
|
44,868
|
|
|
$
|
43,320
|
|
|
$
|
24,616
|
|
Adjustments to reconcile net income to net cash provided by (used in) operating activities:
|
(36,330
|
)
|
|
232,199
|
|
|
(247,530
|
)
|
|||
Net cash provided by (used in) operating activities
|
8,538
|
|
|
275,519
|
|
|
(222,914
|
)
|
|||
Net cash provided by (used in) investing activities
|
(43,320
|
)
|
|
258,339
|
|
|
(433,080
|
)
|
|||
Net cash provided by (used in) financing activities
|
73,057
|
|
|
(541,414
|
)
|
|
652,445
|
|
|||
Change in cash and cash equivalents
|
$
|
38,275
|
|
|
$
|
(7,556
|
)
|
|
$
|
(3,549
|
)
|
(1)
|
The maturity date of the Wells Fargo Facility is subject to two 12-month extensions at our option provided that certain conditions are met and applicable extension fees are paid. Beginning on December 14, 2015, new advances under the Wells Fargo Facility accrue interest at a per annum rate equal to the sum of (i) 30 day LIBOR plus (ii) a pricing margin range of 1.75% to 2.35%. Advances on loans made prior to December 14, 2015 under the Wells Fargo Facility continue to accrue interest at a per annum rate equal to the sum of (i) 30 day LIBOR plus (ii) a pricing margin range of 2.00% to 2.50%. In June 2016, we amended the Wells Fargo Facility to, among other things, increase the size of the facility from $225.0 million to $325.0 million and extend the initial maturity date to December 14, 2017.
|
(2)
|
The Citibank Facility is subject to three 12-month extensions at our option provided that certain conditions are met and applicable extension fees are paid. In July 2016, we entered into an amendment to the Citibank Facility, which added an accordion feature that provides for an increase in the $250.0 million commitment amount with respect to approved assets, as determined by Citibank, N.A. in its sole discretion. In December 2016, we entered into an amendment to the Citibank Facility to extend the initial maturity date to December 10, 2018. Additionally, new advances under the Citibank Facility after December 8, 2016 accrue interest at a per annum rate equal to
one-month LIBOR
plus a pricing margin range of
2.25%
to
2.50%
, subject to certain exceptions.
|
(3)
|
In August 2016, we amended and restated the existing BAML Facility to increase its commitment size from $50.0 million to $125.0 million. Individual advances on loans under the BAML Facility generally have a two-year maturity, subject to a 12-month extension at our option provided that certain conditions are met and applicable extension fees are paid.
|
(4)
|
We have one 12-month extension at our option provided that certain conditions are met and applicable extension fees are paid, which, if exercised, would extend the final maturity of the March 2014 CNB Facility to March 10, 2018. See "Recent Developments" and Note
15
to our consolidated financial statements included in this annual report on Form 10-K for information on a subsequent event relating to the March 2014 CNB Facility.
|
(5)
|
The interest rate of the July 2014 CNB Facility was LIBOR plus 3.00%, comprised of LIBOR plus 1.50% and a credit support fee of 1.50% payable to Ares Management. In July 2016, we amended the July 2014 CNB Facility to extend the maturity date to September 30, 2016. On September 30, 2016, the July 2014 CNB Facility was repaid in full and its terms were not extended.
|
(6)
|
The revolving master repurchase facility with Metropolitan Life Insurance Company (the "MetLife Facility") is subject to two 12-month extensions at our option provided that certain conditions are met and applicable extension fees are paid.
|
(7)
|
The price differential (or interest rate) on the revolving master repurchase facility with UBS Real Estate Securities Inc. (the “April 2014 UBS Facility”) is one-month LIBOR plus (i) 1.88% per annum, for assets that are subject to an advance for one year or less, (ii) 2.08% per annum, for assets that are subject to an advance in excess of one year but less than two years, and (iii) 2.28% per annum, for assets that are subject to an advance for more than two years; in each case, excluding amortization of commitment and exit fees.
|
(8)
|
The December 2014 UBS Facility (together with the April 2014 UBS Facility, the "UBS Facilities") has been repaid in full and its terms were not extended.
|
(9)
|
The U.S. Bank Facility is subject to two 12-month extensions at our option provided that certain conditions are met and applicable extension fees are paid. Advances under the U.S. Bank Facility accrue interest at a per annum rate of one-month LIBOR plus a spread of 2.25%, unless otherwise agreed between U.S. Bank and the Company, depending upon the mortgage loans sold to U.S. Bank in the applicable transaction.
|
(10)
|
The Secured Term Loan has a LIBOR floor of 1.0% on drawn amounts.
|
|
2015
|
||||||
|
Carrying Amount
|
|
Outstanding Principal
|
||||
Commercial mortgage-backed securitization debt (consolidated VIE)
|
$
|
61,815
|
|
|
$
|
61,856
|
|
Collateralized loan obligation securitization debt (consolidated VIE)
|
192,528
|
|
|
193,419
|
|
||
Securitizations debt
|
$
|
254,343
|
|
|
$
|
255,275
|
|
|
Total
|
|
Less than
1 year |
|
1 to 3 years
|
|
3 to 5 years
|
|
More than
5 years |
||||||||||
Wells Fargo Facility
|
$
|
218,064
|
|
|
$
|
218,064
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
Citibank Facility
|
302,240
|
|
|
—
|
|
|
302,240
|
|
|
—
|
|
|
—
|
|
|||||
BAML Facility
|
77,679
|
|
|
—
|
|
|
77,679
|
|
|
—
|
|
|
—
|
|
|||||
March 2014 CNB Facility
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|||||
MetLife Facility
|
53,130
|
|
|
53,130
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|||||
April 2014 UBS Facility
|
71,360
|
|
|
—
|
|
|
71,360
|
|
|
—
|
|
|
—
|
|
|||||
U.S. Bank Facility
|
58,240
|
|
|
—
|
|
|
58,240
|
|
|
—
|
|
|
—
|
|
|||||
Secured Term Loan
|
155,000
|
|
|
—
|
|
|
155,000
|
|
|
—
|
|
|
—
|
|
|||||
Future Loan Funding Commitments
|
69,150
|
|
|
11,680
|
|
|
55,022
|
|
|
2,448
|
|
|
—
|
|
|||||
Total
|
$
|
1,004,863
|
|
|
$
|
282,874
|
|
|
$
|
719,541
|
|
|
$
|
2,448
|
|
|
$
|
—
|
|
Change in Average 30-Day LIBOR
|
|
For the year ended December 31, 2016
|
Up 300 basis points
|
|
$7.6
|
Up 200 basis points
|
|
$5.1
|
Up 100 basis points
|
|
$2.6
|
Down to 0 basis points
|
|
$0.7
|
Class
|
|
Initial Note Balance
|
|
Interest Rate(1)
|
||
Class A
|
|
$
|
170.6
|
|
|
LIBOR + 1.20%
|
Class A-S
|
|
$
|
37.5
|
|
|
LIBOR + 1.40%
|
Class B
|
|
$
|
10.2
|
|
|
LIBOR + 2.25%
|
Class C
|
|
$
|
20.5
|
|
|
LIBOR + 3.05%
|
Class D
|
|
$
|
34.1
|
|
|
LIBOR + 4.75%
|
1.
|
Financial Statements—See the Index to Consolidated Financial Statements on Page F-1.
|
2.
|
Financial Statement Schedules—None. We have omitted financial statement schedules because they are not required or are not applicable, or the required information is shown in the consolidated financial statements or notes to the consolidated financial statements.
|
3.
|
Exhibits.
|
Exhibit
Number
|
|
Exhibit Description
|
|
2.1
|
|
*
|
Purchase and Sale Agreement, among Ares Commercial Real Estate Corporation and Cornerstone Real Estate Advisers LLC (1)
|
2.2
|
|
|
Waiver and Amendment to Purchase and Sale Agreement, dates as of September 29, 2016, among Ares Commercial Real Estate Corporation and Barings Real Estate Advisers LLC (formerly known as Cornerstone Real Estate Advisers LLC).
|
3.1
|
|
*
|
Articles of Amendment and Restatement of Ares Commercial Real Estate Corporation.(2)
|
3.2
|
|
*
|
Amended and Restated Bylaws of Ares Commercial Real Estate Corporation.(3)
|
10.1
|
|
*
|
Registration Rights Agreement, dated April 25, 2012, between Ares Commercial Real Estate Corporation and Ares Investments Holdings LLC.(4)
|
10.2
|
|
*
|
Management Agreement, dated April 25, 2012, between Ares Commercial Real Estate Management LLC and Ares Commercial Real Estate Corporation.(5)
|
10.3
|
|
*
|
First Amendment to Management Agreement, dated as of September 30, 2013, by and between Ares Commercial Real Estate Corporation and Ares Commercial Real Estate Management LLC.(5)
|
10.4
|
|
*
|
Second Amendment to Management Agreement dated November 7, 2014 by and between Ares Commercial Real Estate Corporation and Ares Commercial Real Estate Management LLC.(6)
|
10.5
|
|
*
|
Trademark License Agreement, dated April 25, 2012, between Ares Commercial Real Estate Corporation and Ares Management LLC.(4)
|
10.6
|
|
*
|
2012 Equity Incentive Plan.(3)
|
10.7
|
|
*
|
Form of Restricted Stock Agreement.(7)
|
10.80
|
|
*
|
Form of Indemnification Agreement with directors and certain officers.(4)
|
10.90
|
|
*
|
Form of Indemnification Agreement with members of the Investment Committee and/or Underwriting Committee of Ares Commercial Real Estate Management LLC.(4)
|
10.10
|
|
*
|
Registration Rights Agreement, dated as of August 30, 2013, among Ares Commercial Real Estate Corporation, Alliant Inc. and The Alliant Company, LLC.(8)
|
10.11
|
|
*
|
Amended and Restated Master Repurchase and Securities Contract, dated as of December 20, 2013, among ACRC Lender W LLC and ACRC Lender W TRS LLC, as sellers, and Wells Fargo Bank, National Association, as buyer.(5)
|
10.12
|
|
*
|
Amended and Restated Custodial Agreement, dated as of December 20, 2013, among ACRC Lender W LLC and ACRC Lender W TRS LLC, as sellers, and Wells Fargo Bank, National Association, as buyer and custodian.(5)
|
10.13
|
|
*
|
Amended and Restated Controlled Account Agreement (Waterfall Account), dated as of December 20, 2013, among ACRC Lender W LLC and ACRC Lender W TRS LLC, as debtors, and Wells Fargo Bank, National Association, as secured party and depository bank.(5)
|
10.14
|
|
*
|
Amended and Restated Pledge and Security Agreement, dated as of December 20, 2013, by ACRC Lender LLC, as pledgor, in favor of Wells Fargo Bank, National Association, as secured party.(5)
|
10.15
|
|
*
|
Amended and Restated Guarantee Agreement, dated as of December 20, 2013, by Ares Commercial Real Estate Corporation, as guarantor, in favor of Wells Fargo Bank, National Association, as bank.(5)
|
10.16
|
|
*
|
Credit Agreement, dated as of March 12, 2014, by and among ACRC Lender LLC, as borrower, City National Bank, a national banking association, as arranger and administrative agent, and the lenders party thereto.(9)
|
Exhibit
Number
|
|
Exhibit Description
|
|
10.17
|
|
*
|
General Continuing Guaranty, dated as of March 12, 2014, by Ares Commercial Real Estate Corporation, as guarantor, in favor of City National Bank, a national banking association, as arranger and administrative agent.(9)
|
10.18
|
|
*
|
Security Agreement, dated as of March 12, 2014, by ACRC Lender LLC, as borrower, in favor of City National Bank, a national banking association, as arranger and administrative agent.(9)
|
10.19
|
|
*
|
Intercompany Subordination Agreement, dated as of March 12, 2014, by and among ACRC Lender LLC, as borrower, and Ares Commercial Real Estate Corporation, as guarantor, in favor of City National Bank, a national banking association, as arranger and administrative agent.(9)
|
10.20
|
|
*
|
Master Repurchase Agreement, dated as of April 9, 2014, among ACRC Lender U LLC and ACRC Lender U TRS LLC, as sellers, ACRC Lender U Mezz LLC, as mezzanine subsidiary, Ares Commercial Real Estate Corporation, as guarantor, and UBS Real Estate Securities Inc., as buyer.(10)
|
10.21
|
|
*
|
Guaranty Agreement, dated as of April 9, 2014, by Ares Commercial Real Estate Corporation in favor of UBS Real Estate Securities Inc.(10)
|
10.22
|
|
*
|
Sixth Amended and Restated Mortgage Warehousing Credit and Security Agreement, dated as of May 1, 2014, by and among ACRE Capital LLC, Bank of America, N.A., as agent and lender and the other lenders party thereto.(11)
|
10.23
|
|
*
|
Amendment No. 1 to Amended and Restated Master Repurchase and Securities Contract dated as of May 29, 2014, among ACRC Lender W LLC and ACRC Lender W TRS LLC and Wells Fargo Bank, National Association.(12)
|
10.24
|
|
*
|
Amendment No. 1 to Amended and Restated Guarantee Agreement dated as of May 29, 2014, by Ares Commercial Real Estate Corporation, as guarantor, in favor of Wells Fargo Bank, National Association, as buyer.(12)
|
10.25
|
|
*
|
Credit Agreement, dated as of July 30, 2014, by and among ACRC Lender LLC, as borrower, City National Bank, a national banking association, as arranger and administrative agent, and the lenders party thereto.(13)
|
10.26
|
|
*
|
General Continuing Guaranty, dated as of July 30, 2014, by Ares Commercial Real Estate Corporation, as guarantor, in favor of City National Bank, a national banking association, as arranger and administrative agent.(13)
|
10.27
|
|
*
|
Intercompany Subordination Agreement, dated as of July 30, 2014, by and among ACRC Lender LLC, as borrower, and Ares Commercial Real Estate Corporation, as guarantor, in favor of City National Bank, a national banking association, as arranger and administrative agent.(13)
|
10.28
|
|
*
|
Credit Support Fee Agreement, dated as of July 30, 2014, by and among Ares Commercial Real Estate Corporation, ACRC Holdings LLC, ACRC Lender LLC and Ares Management LLC.(13)
|
10.29
|
|
*
|
Amendment Number One to Credit Agreement and Consent, dated as of July 30, 2014, by and among ACRC Lender LLC, as borrower, City National Bank, a national banking association, as arranger and administrative agent, and the lenders party thereto.(13)
|
10.30
|
|
*
|
Master Repurchase Agreement, dated as of August 13, 2014, between ACRC Lender ML LLC, as seller, and Metropolitan Life Insurance Company, as buyer.(14)
|
10.31
|
|
*
|
Guaranty, dated as of August 13, 2014, by Ares Commercial Real Estate Corporation in favor of Metropolitan Life Insurance Company.(14)
|
10.32
|
|
*
|
Indenture dated as of August 15, 2014 among ACRE Commercial Mortgage 2014‑FL2 Ltd, as issuer, ACRE Commercial Mortgage 2014‑FL2 LLC as co‑issuer, Wilmington Trust, National Association, as trustee, Wells Fargo Bank, National Association, as note administrator, paying agent, calculation agent, transfer agent, authentication agent and custodian, and Wells Fargo Bank, National Association, as advancing agent.(15)
|
10.33
|
|
*
|
Mortgage Asset Purchase Agreement dated as of August 15, 2014 between ACRC Lender LLC, as seller and ACRE Commercial Mortgage 2014‑FL2 Ltd., as issuer, and agreed and acknowledged by the Company.(15)
|
10.34
|
|
*
|
Amendment No. 1 to Sixth Amended and Restated Mortgage Warehousing Credit and Security Agreement, dated as of November 24 2014, by and among ACRE Capital LLC, as borrower, Bank of America, N.A., as agent and lender and the other lenders party thereto.(16)
|
10.35
|
|
*
|
Master Repurchase Agreement, dated as of December 8, 2014, by and between ACRC Lender C LLC, as seller, and Citibank, N.A., as buyer.(17)
|
10.36
|
|
*
|
Omnibus Amendment To Other Transaction Documents and Reaffirmation of Guaranty, dated as of December 8, 2014, by and among ACRC Lender C LLC, ACRC Lender LLC, Ares Commercial Real Estate Corporation and Citibank, N.A.(17)
|
10.37
|
|
*
|
Amendment No. 2 to Amended and Restated Master Repurchase and Securities Contract dated as of December 12, 2014, among ACRC Lender W LLC and ACRC Lender W TRS LLC, as sellers, and Wells Fargo Bank, National Association, as buyer.(18)
|
Exhibit
Number
|
|
Exhibit Description
|
|
10.38
|
|
*
|
Amendment No. 2 to Sixth Amended and Restated Mortgage Warehousing Credit and Security Agreement, dated as of February 27, 2015, by and among ACRE Capital LLC, Bank of America, N.A., as Agent and Lender and the other Lenders party thereto.(19)
|
10.39
|
|
*
|
Amendment No. 3 to Sixth Amended and Restated Mortgage Warehousing Credit and Security Agreement, dated as of April 15, 2015, by and among ACRE Capital LLC, Bank of America, N.A., as Agent and Lender and the other Lenders party thereto.(20)
|
10.40
|
|
*
|
Bridge Loan Warehousing Credit and Security Agreement, dated as of May 27, 2015, by and among ACRC Lender B LLC, Bank of America, N.A., as Administrative Agent and Lender and the other Lenders.(21)
|
10.41
|
|
*
|
Guaranty Agreement, dated as of May 27, 2015, by Ares Commercial Real Estate Corporation, in favor of Bank of America, N.A., as Administrative Agent and Lender and for the benefit of the other Lenders.(21)
|
10.42
|
|
*
|
Pledge and Security Agreement, dated as of May 27, 2015, by and between ACRC Lender LLC and Bank of America, N.A., as Administrative Agent and Lender and for the benefit of the other Lenders.(21)
|
10.43
|
|
*
|
Amendment No. 2 to Master Repurchase Agreement dated as of October 21, 2015, among ACRC Lender U LLC and ACRC Lender U TRS LLC, as sellers, ACRC Lender U Mezz LLC, as mezzanine subsidiary, Ares Commercial Real Estate Corporation, as guarantor and UBS Real Estate Securities, Inc., as buyer.(22)
|
10.44
|
|
*
|
Credit and Guaranty Agreement, dated as of December 9, 2015 by and among Ares Commercial Real Estate Corporation, as borrower and ACRC Holdings LLC, ACRC Mezz Holdings LLC, ACRC CP Investor LLC and ACRC Warehouse Holdings LLC, as guarantors, the lenders party thereto, Highbridge Principal Strategies, LLC, as administrative agent and DBD Credit Funding LLC, as collateral agent.(23)
|
10.45
|
|
*
|
Pledge and Security Agreement, dated as of December 9, 2015 among Ares Commercial Real Estate Corporation, ACRC Holdings LLC, ACRC Mezz Holdings LLC, ACRC CP Investor LLC, ACRC Warehouse Holdings LLC and ACRC Lender and DBD Credit Funding LLC, as collateral agent for the lenders.(23)
|
10.46
|
|
*
|
Negative Pledge Agreement, dated as of December 9, 2015 by Ares Commercial Real Estate Corporation, ACRC KA JV Investor LLC, ACRC Lender LLC, ACRC Champions Investor LLC and ACRE Capital Holdings LLC in favor of DBD Credit Funding LLC, as collateral agent for the lenders.(23)
|
10.47
|
|
*
|
Amendment No. 5 to Amended and Restated Master Repurchase and Securities Contract and Amended and Restated Guarantee Agreement dated as of December 14, 2015, among ACRC Lender W LLC, ACRC Lender W TRS LLC and Ares Commercial Real Estate Corporation and Wells Fargo Bank, National Association.(24)
|
10.48
|
|
*
|
Amendment No. 2 to Bridge Loan Warehousing Credit and Security Agreement dated as of February 26, 2016, among ACRC Lender B LLC and Bank Of America, N.A.(25)
|
10.49
|
|
*
|
Amendment No. 3 to Credit Agreement dated as of February 26, 2016, by and among ACRC Lender LLC, as borrower, City National Bank, a national banking association, as arranger and administrative agent, and the lenders party thereto. (25)
|
10.50
|
|
*
|
Amendment No. 3 to Bridge Loan Warehousing Credit and Security Agreement dated as of May 26, 2016, among ACRC Lender B LLC and Bank of America, N.A. (26)
|
10.51
|
|
*
|
Amendment No. 6 to Amended and Restated Master Repurchase and Securities Contract and Amended and Restated Guarantee Agreement dated as of June 30, 2016, among ACRC Lender W LLC, ACRC Lender W TRS LLC and Ares Commercial Real Estate Corporation and Wells Fargo Bank, National Association. (27)
|
10.52
|
|
*
|
Amendment No. 5 to Sixth Amended and Restated Mortgage Warehousing Credit and Security Agreement, dated as of June 30, 2016, by and among ACRE Capital LLC, Bank of America, N.A., as Agent and Lender and the other Lenders party thereto. (27)
|
10.53
|
|
*
|
Second Amendment to Master Repurchase Agreement and Guaranty dated as of July 13, 2016, among ACRC Lender C LLC, as borrower, Ares Commercial Real Estate Corporation, as guarantor, and Citibank, N.A., as lender. (28)
|
10.54
|
|
*
|
First Amendment to Master Repurchase Agreement and Guaranty dated as of July 13, 2016, among ACRC Lender C LLC, as borrower, Ares Commercial Real Estate Corporation, as guarantor, and Citibank, N.A., as lender. (29)
|
10.55
|
|
*
|
Amendment No. 2 to Credit Agreement dated as of July 29, 2016, by and among ACRC Lender LLC, City National Bank, a national banking association, as arranger and administrative agent, and the lenders party thereto. (29)
|
10.56
|
|
*
|
Amendment No. 6 to Sixth Amended and Restated Mortgage Warehousing Credit and Security Agreement dated of July 29, 2016, by and among ACRE Capital LLC, Bank of America, N.A., as Agent and Lender and the other Lenders party thereto. (29)
|
10.57
|
|
*
|
Master Repurchase and Securities Contract dated as of August 1, 2016, between ACRC Lender US LLC and U.S. Bank National Association. (29)
|
10.58
|
|
*
|
Payment Guaranty, dated as of August 1, 2016, by Ares Commercial Real Estate Corporation in favor of U.S. Bank National Association. (29)
|
Exhibit
Number
|
|
Exhibit Description
|
|
10.59
|
|
*
|
Amended and Restated Bridge Loan Warehousing Credit and Security Agreement, dated as of August 8, 2016, by and among ACRC Lender B LLC, Bank of America, N.A., as Administrative Agent and Lender and the other Lenders. (30)
|
10.60
|
|
*
|
Amendment to Guaranty, dated as of September 22, 2016, by Ares Commercial Real Estate Corporation, as guarantor, and Metropolitan Life Insurance Company, as buyer. (31)
|
10.61
|
|
*
|
Amendment No. 7 to Sixth Amended and Restated Mortgage Warehousing Credit and Security Agreement, dated as of September 27, 2016, by and among ACRE Capital LLC, Bank of America, N.A., as Agent and Lender and the other Lenders party thereto. (31)
|
10.62
|
|
|
Assignment and Amendment No. 1 to Custodial Agreement, dated November 2, 2016, among ACRC Lender U LLC and ACRC Lender U TRS LLC, as sellers, ACRC Lender U Mezz LLC, as mezzanine subsidiary, UBS Real Estate Securities Inc., as assignor, UBS AG, as assignee, and Wells Fargo Bank, N.A., as Custodian.
|
10.63
|
|
|
Assignment and Amendment No. 3 to Master Repurchase Agreement, dated November 2, 2016, among ACRC Lender U LLC and ACRC Lender U TRS LLC, as sellers, ACRC Lender U Mezz LLC, as mezzanine subsidiary, UBS Real Estate Securities, Inc., as assignor, UBS AG, as assignee, and Ares Commercial Real Estate Corporation, as guarantor.
|
10.64
|
|
|
Assignment and Reaffirmation of Guaranty, dated November 2, 2016, among UBS Real Estate Securities Inc., as assignor, UBS AG, as assignee, and Ares Commercial Real Estate Corporation, as guarantor.
|
10.65
|
|
*
|
Amendment No. 3 to Master Repurchase Agreement dated as of December 8, 2016, by and among, ACRC Lender C LLC, Ares Commercial Real Estate Corporation, as Guarantor, and Citibank, N.A., a national banking association, as Buyer. (32)
|
10.66
|
|
|
Amendment No. 4 to Credit Agreement and Amendment No. 1 to General Continuing Guaranty dated as of December 27, 2016, by and among, by and among ACRC Lender LLC, as borrower, Ares Commercial Real Estate Corporation, as Guarantor and City National Bank, a national banking association, as administrative agent, and the lenders party thereto.
|
10.67
|
|
|
Reaffirmation and Consent to Amendment No. 4 to Credit Agreement and Amendment No. 1 to General Continuing Guaranty dated as of December 27, 2016, by and among, by and among ACRC Lender LLC, as borrower, Ares Commercial Real Estate Corporation, as Guarantor and City National Bank, a national banking association, as administrative agent, and the lenders party thereto.
|
21.10
|
|
*
|
Subsidiaries of Ares Commercial Real Estate Corporation
|
23.10
|
|
*
|
Consent of Ernst & Young LLP
|
31.10
|
|
*
|
Certification of Co‑Chief Executive Officer pursuant to Rule 13a‑14(a) and Rule 15d‑14(a), as adopted pursuant to Section 302 of the Sarbanes‑Oxley Act of 2002
|
31.20
|
|
*
|
Certification of Co‑Chief Executive Officer pursuant to Rule 13a‑14(a) and Rule 15d‑14(a), as adopted pursuant to Section 302 of the Sarbanes‑Oxley Act of 2002
|
31.30
|
|
*
|
Certification of Chief Financial Officer pursuant to Rule 13a‑14(a) and Rule 15d‑14(a), as adopted pursuant to Section 302 of the Sarbanes‑Oxley Act of 2002
|
32.10
|
|
*
|
Certification of Co‑Chief Executive Officers and Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes‑Oxley Act of 2002
|
101.INS
|
|
*
|
XBRL Instance Document
|
101.SCH
|
|
*
|
XBRL Taxonomy Extension Schema Document
|
101.CAL
|
|
*
|
XBRL Taxonomy Extension Calculation Linkbase Document
|
101.LAB
|
|
*
|
XBRL Taxonomy Extension Label Linkbase Document
|
101.PRE
|
|
*
|
XBRL Taxonomy Extension Presentation Linkbase Document
|
101.DEF
|
|
*
|
XBRL Taxonomy Extension Definition Linkbase Document
|
*
|
Previously filed
|
(1)
|
Incorporated by reference to Exhibit 2.1 to the Company’s Form 8-K (File No. 001-35517) filed on June 29, 2016.
|
(2)
|
Incorporated by reference to Exhibit 3.1 to the Company’s Form 10-K (File No. 001-35517), filed on March 1, 2016.
|
(3)
|
Incorporated by reference to Exhibits 3.2 and 10.1, as applicable, to the Company’s Form S‑8 (File No. 333‑181077), filed on May 1, 2012
|
(4)
|
Incorporated by reference to Exhibits 10.1, 10.3, 10.4 and 10.5, as applicable, to the Company’s Form 8‑K (File No. 001‑35517), filed on May 4, 2012.
|
(5)
|
Incorporated by reference to Exhibit 10.11, 10.12, 10.13, 10.14, 10.15, 10.17 and 10.18 to the Company’s Form 10‑K (File No. 001‑35517), filed on March 17, 2014.
|
(6)
|
Incorporated by reference to Exhibit 10.11 to the Company’s Form 10‑Q (File No. 001‑35517), filed on November 10, 2014.
|
(7)
|
Incorporated by reference to Exhibit 10.4 to the Company’s Registration Statement on Amendment No. 3 to Form S‑11/A (File No. 333‑176841), filed on April 12, 2012.
|
(8)
|
Incorporated by reference to Exhibit 10.7 to the Company’s Form 10‑Q (File No. 001‑35517), filed on November 13, 2013.
|
(9)
|
Incorporated by reference to Exhibits 10.1, 10.2, 10.3 and 10.4, as applicable, to the Company’s Form 8‑K (File No. 001‑35517), filed on March 14, 2014.
|
(10)
|
Incorporated by reference to Exhibits 10.1 and 10.2, as applicable, to the Company’s Form 8‑K (File No. 001‑35517), filed on April 15, 2014.
|
(11)
|
Incorporated by reference to Exhibit 10.1 to the Company’s Form 8‑K (File No. 001‑35517), filed on May 6, 2014.
|
(12)
|
Incorporated by reference to Exhibits 10.1 and 10.2, as applicable, to the Company’s Form 8‑K (File No. 001‑35517), filed on June 3, 2014.
|
(13)
|
Incorporated by reference to Exhibits 10.1, 10.2, 10.3, 10.4 and 10.6, as applicable, to the Company’s Form 8‑K (File No. 001‑35517), filed on July 31, 2014.
|
(14)
|
Incorporated by reference to Exhibits 10.1 and 10.2, as applicable, to the Company’s Form 8‑K (File No. 001‑35517), filed on August 18, 2014.
|
(15)
|
Incorporated by reference to Exhibits 10.1 and 10.2, as applicable, to the Company’s Form 8‑K (File No. 001‑35517), filed on August 19, 2014.
|
(16)
|
Incorporated by reference to Exhibit 10.1 to the Company’s Form 8‑K (File No. 001‑35517), filed on December 1, 2014.
|
(17)
|
Incorporated by reference to Exhibits 10.1 and 10.2, as applicable, to the Company’s Form 8‑K (File No. 001‑35517), filed on December 12, 2014.
|
(18)
|
Incorporated by reference to Exhibit 10.1 to the Company’s Form 8‑K (File No. 001‑35517), filed on December 18, 2014.
|
(19)
|
Incorporated by reference to Exhibit 10.1 to the Company’s Form 8‑K (File No. 001‑35517), filed on March 5, 2015.
|
(20)
|
Incorporated by reference to Exhibit 10.1 to the Company’s Form 8‑K (File No. 001‑35517), filed on April 20, 2015.
|
(21)
|
Incorporated by reference to Exhibits 10.1, 10.2 and 10.3, as applicable, to the Company’s Form 8‑K (File No. 001‑35517), filed on June 2, 2015.
|
(22)
|
Incorporated by reference to Exhibits 10.1 to the Company’s Form 8‑K (File No. 001‑35517), filed on October 26, 2015.
|
(23)
|
Incorporated by reference to Exhibits 10.1, 10.2 and 10.3, as applicable, to the Company’s Form 8‑K (File No. 001‑35517), filed on December 14, 2015.
|
(24)
|
Incorporated by reference to Exhibit 10.1 to the Company’s Form 8‑K (File No. 001‑35517), filed on December 17, 2015.
|
(25)
|
Incorporated by reference to Exhibits 10.52 and 10.53, as applicable, to the Company’s Form 10-K (File No. 001-35517), filed on March 1, 2016.
|
(26)
|
Incorporated by reference to Exhibit 10.1 to the Company’s Form 8-K (file No. 001-35517), filed on June 1, 2016.
|
(27)
|
Incorporated by reference to Exhibit 10.1 and 10.2, as applicable, to the Company’s Form 8-K (file No. 001-35517), filed on July 7, 2016.
|
(28)
|
Incorporated by reference to Exhibit 10.1 to the Company’s Form 8-K (File No. 001-35517), filed on July 19, 2016
|
(29)
|
Incorporated by reference to Exhibit 10.4, 10.6, 10.7, 10.8 and 10.9, as applicable, to the Company’s Form 10Q (File No. 001-35517) filed on August 4, 2016.
|
(31)
|
Incorporated by reference to Exhibit 10.11 and 10.12, as applicable, to the Company’s Form 10Q (File No. 001-35517) filed on November 3, 2016.
|
(32)
|
Incorporated by reference to Exhibit 10.1 to the Company’s Form 8-K (File No. 001-35517), filed on December 12, 2016.
|
|
As of December 31,
|
||||||
|
2016
|
|
2015
|
||||
ASSETS
|
|
|
|
|
|||
Cash and cash equivalents ($8 and $8 related to consolidated VIEs, respectively)
|
$
|
47,270
|
|
|
$
|
5,066
|
|
Restricted cash
|
375
|
|
|
13,083
|
|
||
Loans held for investment ($21,514 and $483,572 related to consolidated VIEs, respectively)
|
1,313,937
|
|
|
1,174,391
|
|
||
Other assets ($203 and $2,695 of interest receivable related to consolidated VIEs, respectively; $35,607 of other receivables related to consolidated VIEs as of December 31, 2015)
|
12,121
|
|
|
53,191
|
|
||
Assets of discontinued operations
|
—
|
|
|
133,251
|
|
||
Total assets
|
$
|
1,373,703
|
|
|
$
|
1,378,982
|
|
LIABILITIES AND EQUITY
|
|
|
|
||||
LIABILITIES
|
|
|
|
||||
Secured funding agreements
|
$
|
780,713
|
|
|
$
|
522,775
|
|
Secured term loan
|
149,878
|
|
|
69,762
|
|
||
Commercial mortgage-backed securitization debt (consolidated VIE)
|
—
|
|
|
61,815
|
|
||
Collateralized loan obligation securitization debt (consolidated VIE)
|
—
|
|
|
192,528
|
|
||
Due to affiliate
|
2,699
|
|
|
2,424
|
|
||
Dividends payable
|
7,406
|
|
|
7,152
|
|
||
Other liabilities ($299 of interest payable related to consolidated VIEs as of December 31, 2015)
|
3,334
|
|
|
14,507
|
|
||
Liabilities of discontinued operations
|
—
|
|
|
51,531
|
|
||
Total liabilities
|
944,030
|
|
|
922,494
|
|
||
Commitments and contingencies (Note 5)
|
|
|
|
|
|
||
EQUITY
|
|
|
|
|
|
||
Common stock, par value $0.01 per share, 450,000,000 shares authorized at December 31, 2016 and 2015, 28,482,756 and 28,609,650 shares issued and outstanding at December 31, 2016 and 2015, respectively
|
283
|
|
|
284
|
|
||
Additional paid-in capital
|
420,056
|
|
|
421,179
|
|
||
Accumulated deficit
|
(1,310
|
)
|
|
(11,992
|
)
|
||
Total stockholders' equity
|
419,029
|
|
|
409,471
|
|
||
Non-controlling interests in consolidated VIEs
|
10,644
|
|
|
47,017
|
|
||
Total equity
|
429,673
|
|
|
456,488
|
|
||
Total liabilities and equity
|
$
|
1,373,703
|
|
|
$
|
1,378,982
|
|
|
For the years ended December 31,
|
||||||||||
|
2016
|
|
2015
|
|
2014
|
||||||
Revenue:
|
|
|
|
|
|
|
|||||
Interest income from loans held for investment
|
$
|
81,963
|
|
|
$
|
86,337
|
|
|
$
|
70,495
|
|
Interest expense
|
(36,856
|
)
|
|
(36,342
|
)
|
|
(33,637
|
)
|
|||
Net interest margin
|
45,107
|
|
|
49,995
|
|
|
36,858
|
|
|||
Gain on sale of loans
|
—
|
|
|
—
|
|
|
680
|
|
|||
Total revenue
|
45,107
|
|
|
49,995
|
|
|
37,538
|
|
|||
Expenses:
|
|
|
|
|
|
|
|
|
|||
Management and incentive fees to affiliate
|
5,956
|
|
|
5,397
|
|
|
5,440
|
|
|||
Professional fees
|
2,228
|
|
|
2,018
|
|
|
2,686
|
|
|||
Acquisition and investment pursuit costs
|
—
|
|
|
—
|
|
|
20
|
|
|||
General and administrative expenses
|
2,801
|
|
|
2,830
|
|
|
3,003
|
|
|||
General and administrative expenses reimbursed to affiliate
|
3,441
|
|
|
3,426
|
|
|
3,400
|
|
|||
Total expenses
|
14,426
|
|
|
13,671
|
|
|
14,549
|
|
|||
Income from continuing operations before income taxes
|
30,681
|
|
|
36,324
|
|
|
22,989
|
|
|||
Income tax expense (benefit), including excise tax
|
230
|
|
|
(11
|
)
|
|
240
|
|
|||
Net income from continuing operations
|
30,451
|
|
|
36,335
|
|
|
22,749
|
|
|||
Net income from operations of discontinued operations, net of income taxes
|
4,221
|
|
|
6,985
|
|
|
1,867
|
|
|||
Gain on sale of discontinued operations
|
10,196
|
|
|
—
|
|
|
—
|
|
|||
Net income attributable to ACRE
|
44,868
|
|
|
43,320
|
|
|
24,616
|
|
|||
Less: Net income attributable to non-controlling interests
|
(4,532
|
)
|
|
(9,035
|
)
|
|
(220
|
)
|
|||
Net income attributable to common stockholders
|
$
|
40,336
|
|
|
$
|
34,285
|
|
|
$
|
24,396
|
|
Basic earnings per common share:
|
|
|
|
|
|
||||||
Continuing operations
|
$
|
0.91
|
|
|
$
|
0.96
|
|
|
$
|
0.79
|
|
Discontinued operations
|
0.51
|
|
|
0.25
|
|
|
0.07
|
|
|||
Net income
|
$
|
1.42
|
|
|
$
|
1.20
|
|
|
$
|
0.86
|
|
Diluted earnings per common share:
|
|
|
|
|
|
||||||
Continuing operations
|
$
|
0.91
|
|
|
$
|
0.95
|
|
|
$
|
0.79
|
|
Discontinued operations
|
0.51
|
|
|
0.24
|
|
|
0.07
|
|
|||
Net income
|
$
|
1.41
|
|
|
$
|
1.20
|
|
|
$
|
0.85
|
|
Weighted average number of common shares outstanding:
|
|
|
|
|
|
|
|
|
|||
Basic weighted average shares of common stock outstanding
|
28,461,853
|
|
|
28,501,897
|
|
|
28,459,309
|
|
|||
Diluted weighted average shares of common stock outstanding
|
28,523,306
|
|
|
28,597,568
|
|
|
28,585,022
|
|
|
Common Stock
|
|
Additional
Paid-in
Capital
|
|
Accumulated
Deficit
|
|
Total Stockholders' Equity
|
|
Non-Controlling
Interests
|
|
Total
Equity
|
|||||||||||||||
|
Shares
|
|
Amount
|
|||||||||||||||||||||||
Balance at December 31, 2013
|
28,506,977
|
|
|
$
|
284
|
|
|
$
|
419,405
|
|
|
$
|
(13,473
|
)
|
|
$
|
406,216
|
|
|
$
|
—
|
|
|
$
|
406,216
|
|
Stock‑based compensation
|
79,938
|
|
|
—
|
|
|
939
|
|
|
—
|
|
|
939
|
|
|
—
|
|
|
939
|
|
||||||
Net income
|
—
|
|
|
—
|
|
|
—
|
|
|
24,396
|
|
|
24,396
|
|
|
220
|
|
|
24,616
|
|
||||||
Dividends declared
|
—
|
|
|
—
|
|
|
—
|
|
|
(28,597
|
)
|
|
(28,597
|
)
|
|
—
|
|
|
(28,597
|
)
|
||||||
Contributions from non‑controlling interests
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
77,712
|
|
|
77,712
|
|
||||||
Balance at December 31, 2014
|
28,586,915
|
|
|
$
|
284
|
|
|
$
|
420,344
|
|
|
$
|
(17,674
|
)
|
|
$
|
402,954
|
|
|
$
|
77,932
|
|
|
$
|
480,886
|
|
Stock‑based compensation
|
22,735
|
|
|
—
|
|
|
835
|
|
|
—
|
|
|
835
|
|
|
—
|
|
|
835
|
|
||||||
Net income
|
—
|
|
|
—
|
|
|
—
|
|
|
34,285
|
|
|
34,285
|
|
|
9,035
|
|
|
43,320
|
|
||||||
Dividends declared
|
—
|
|
|
—
|
|
|
—
|
|
|
(28,603
|
)
|
|
(28,603
|
)
|
|
—
|
|
|
(28,603
|
)
|
||||||
Contributions from non-controlling interests
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
5,685
|
|
|
5,685
|
|
||||||
Distributions to non-controlling interests
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(45,635
|
)
|
|
(45,635
|
)
|
||||||
Balance at December 31, 2015
|
28,609,650
|
|
|
$
|
284
|
|
|
$
|
421,179
|
|
|
$
|
(11,992
|
)
|
|
$
|
409,471
|
|
|
$
|
47,017
|
|
|
$
|
456,488
|
|
Stock‑based compensation
|
3,022
|
|
|
—
|
|
|
312
|
|
|
—
|
|
|
312
|
|
|
—
|
|
|
312
|
|
||||||
Repurchase and retirement of common stock
|
(129,916
|
)
|
|
(1
|
)
|
|
(1,435
|
)
|
|
—
|
|
|
(1,436
|
)
|
|
—
|
|
|
(1,436
|
)
|
||||||
Net income
|
—
|
|
|
—
|
|
|
—
|
|
|
40,336
|
|
|
40,336
|
|
|
4,532
|
|
|
44,868
|
|
||||||
Dividends declared
|
—
|
|
|
—
|
|
|
—
|
|
|
(29,654
|
)
|
|
(29,654
|
)
|
|
—
|
|
|
(29,654
|
)
|
||||||
Contributions from non-controlling interests
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
11
|
|
|
11
|
|
||||||
Distributions to non-controlling interests
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(40,916
|
)
|
|
(40,916
|
)
|
||||||
Balance at December 31, 2016
|
28,482,756
|
|
|
$
|
283
|
|
|
$
|
420,056
|
|
|
$
|
(1,310
|
)
|
|
$
|
419,029
|
|
|
$
|
10,644
|
|
|
$
|
429,673
|
|
|
For the years ended December 31,
|
||||||||||
|
2016
|
|
2015
|
|
2014
|
||||||
Operating activities:
|
|
|
|
|
|
||||||
Net income
|
$
|
44,868
|
|
|
$
|
43,320
|
|
|
$
|
24,616
|
|
Adjustments to reconcile net income to net cash provided by (used in) operating activities (inclusive of amounts related to discontinued operations):
|
|
|
|
|
|
|
|
|
|||
Amortization of deferred financing costs
|
6,439
|
|
|
9,559
|
|
|
9,716
|
|
|||
Change in mortgage banking activities
|
(10,386
|
)
|
|
(12,596
|
)
|
|
(7,955
|
)
|
|||
Change in fair value of mortgage servicing rights
|
6,457
|
|
|
8,798
|
|
|
7,650
|
|
|||
Accretion of deferred loan origination fees and costs
|
(5,924
|
)
|
|
(4,979
|
)
|
|
(3,661
|
)
|
|||
Provision for loss sharing
|
(146
|
)
|
|
(1,093
|
)
|
|
(1,364
|
)
|
|||
Cash paid to settle loss sharing obligations
|
(681
|
)
|
|
(2,264
|
)
|
|
(2,581
|
)
|
|||
Originations of mortgage loans held for sale
|
(639,413
|
)
|
|
(681,928
|
)
|
|
(497,258
|
)
|
|||
Sale of mortgage loans held for sale to third parties
|
571,714
|
|
|
850,816
|
|
|
302,886
|
|
|||
Stock-based compensation
|
312
|
|
|
835
|
|
|
939
|
|
|||
Gain on sale of discontinued operations
|
(10,196
|
)
|
|
—
|
|
|
—
|
|
|||
Depreciation expense
|
167
|
|
|
219
|
|
|
160
|
|
|||
Deferred tax expense
|
2,049
|
|
|
2,093
|
|
|
93
|
|
|||
Changes in operating assets and liabilities:
|
|
|
|
|
|
|
|
|
|||
Restricted cash
|
1,415
|
|
|
38,956
|
|
|
(43,811
|
)
|
|||
Other assets
|
40,016
|
|
|
20,040
|
|
|
(10,892
|
)
|
|||
Due to affiliate
|
380
|
|
|
(77
|
)
|
|
(61
|
)
|
|||
Other liabilities
|
1,467
|
|
|
3,820
|
|
|
(1,391
|
)
|
|||
Net cash provided by (used in) operating activities
|
8,538
|
|
|
275,519
|
|
|
(222,914
|
)
|
|||
Investing activities:
|
|
|
|
|
|
|
|
|
|||
Issuance of and fundings on loans held for investment
|
(861,444
|
)
|
|
(228,500
|
)
|
|
(711,136
|
)
|
|||
Principal repayment of loans held for investment
|
721,684
|
|
|
411,740
|
|
|
193,867
|
|
|||
Proceeds from sale of a mortgage loan held for sale
|
—
|
|
|
74,625
|
|
|
80,197
|
|
|||
Receipt of origination fees
|
6,813
|
|
|
1,078
|
|
|
7,082
|
|
|||
Proceeds from sale of discontinued operations, net of cash sold
|
89,981
|
|
|
—
|
|
|
—
|
|
|||
Purchases of other assets
|
(354
|
)
|
|
(604
|
)
|
|
(1,831
|
)
|
|||
Payments for acquisition of mortgage servicing rights
|
—
|
|
|
—
|
|
|
(1,259
|
)
|
|||
Net cash provided by (used in) investing activities
|
(43,320
|
)
|
|
258,339
|
|
|
(433,080
|
)
|
|||
Financing activities:
|
|
|
|
|
|
|
|
|
|||
Proceeds from secured funding agreements
|
1,288,698
|
|
|
345,434
|
|
|
1,143,342
|
|
|||
Repayments of secured funding agreements
|
(1,030,760
|
)
|
|
(375,458
|
)
|
|
(854,962
|
)
|
|||
Payment of secured funding costs
|
(5,563
|
)
|
|
(8,013
|
)
|
|
(10,841
|
)
|
|||
Proceeds from issuance of debt of consolidated VIEs
|
—
|
|
|
—
|
|
|
308,703
|
|
|||
Repayments of debt of consolidated VIEs
|
(255,275
|
)
|
|
(272,471
|
)
|
|
(175,984
|
)
|
|||
Payment of offering costs
|
—
|
|
|
—
|
|
|
(113
|
)
|
|||
Proceeds from warehouse lines of credit
|
863,382
|
|
|
804,935
|
|
|
544,011
|
|
|||
Repayments of warehouse lines of credit
|
(795,684
|
)
|
|
(973,294
|
)
|
|
(350,846
|
)
|
|||
Proceeds from secured term loan
|
80,000
|
|
|
75,000
|
|
|
—
|
|
|||
Repayment of convertible debt
|
—
|
|
|
(69,000
|
)
|
|
—
|
|
|||
Repurchase of common stock
|
(1,436
|
)
|
|
—
|
|
|
—
|
|
|||
Dividends paid
|
(29,400
|
)
|
|
(28,597
|
)
|
|
(28,577
|
)
|
|||
Contributions from non-controlling interests
|
11
|
|
|
5,685
|
|
|
77,712
|
|
|||
Distributions to non-controlling interests
|
(40,916
|
)
|
|
(45,635
|
)
|
|
—
|
|
|||
Net cash provided by (used in) financing activities
|
73,057
|
|
|
(541,414
|
)
|
|
652,445
|
|
|||
Change in cash and cash equivalents
|
38,275
|
|
|
(7,556
|
)
|
|
(3,549
|
)
|
|||
Cash and cash equivalents of continuing operations, beginning of period
|
5,066
|
|
|
15,045
|
|
|
14,444
|
|
|||
Cash and cash equivalents of discontinued operations, beginning of period
|
3,929
|
|
|
1,506
|
|
|
5,656
|
|
|||
Cash and cash equivalents, end of period
|
$
|
47,270
|
|
|
$
|
8,995
|
|
|
$
|
16,551
|
|
Cash and cash equivalents of continuing operations, end of period
|
$
|
47,270
|
|
|
$
|
5,066
|
|
|
$
|
15,045
|
|
Cash and cash equivalents of discontinued operations, end of period
|
$
|
—
|
|
|
$
|
3,929
|
|
|
$
|
1,506
|
|
Supplemental Information:
|
|
|
|
|
|
|
|
|
|||
Interest paid during the period
|
$
|
30,066
|
|
|
$
|
28,731
|
|
|
$
|
23,870
|
|
Income taxes paid during the period
|
$
|
—
|
|
|
$
|
83
|
|
|
$
|
430
|
|
Supplemental disclosure of noncash investing and financing activities:
|
|
|
|
|
|
|
|
|
|||
Dividends declared, but not yet paid
|
$
|
7,406
|
|
|
$
|
7,152
|
|
|
$
|
7,147
|
|
Notes receivable related to consolidated VIEs
|
$
|
—
|
|
|
$
|
35,607
|
|
|
$
|
16,116
|
|
|
|
For the years ended December 31,
|
||||||||||
|
|
2016
|
|
2015
|
|
2014
|
||||||
Interest income from loans held for investment, excluding non-controlling interests
|
|
$
|
77,424
|
|
|
$
|
77,278
|
|
|
$
|
70,188
|
|
Interest income from non-controlling interest investment held by third parties
|
|
4,539
|
|
|
9,059
|
|
|
307
|
|
|||
Interest income from loans held for investment
|
|
$
|
81,963
|
|
|
$
|
86,337
|
|
|
$
|
70,495
|
|
|
|
For the years ended December 31,
|
||||||||||
|
|
2016
|
|
2015
|
|
2014
|
||||||
Secured funding agreements and securitizations debt
|
|
$
|
27,856
|
|
|
$
|
29,740
|
|
|
$
|
27,299
|
|
Secured term loan
|
|
9,000
|
|
|
388
|
|
|
—
|
|
|||
Convertible notes
|
|
—
|
|
|
6,214
|
|
|
6,338
|
|
|||
Interest expense
|
|
$
|
36,856
|
|
|
$
|
36,342
|
|
|
$
|
33,637
|
|
|
As of December 31, 2016
|
||||||||||||||
|
Carrying Amount (1)
|
|
Outstanding Principal (1)
|
|
Weighted Average Interest Rate
|
|
Weighted Average Unleveraged Effective Yield (2)
|
|
Weighted Average Remaining Life (Years)
|
||||||
Senior mortgage loans
|
$
|
1,181,569
|
|
|
$
|
1,188,425
|
|
|
4.7
|
%
|
|
5.7
|
%
|
|
1.8
|
Subordinated debt and preferred equity investments
|
121,828
|
|
|
123,230
|
|
|
10.7
|
%
|
|
11.5
|
%
|
|
4.1
|
||
Total loans held for investment portfolio (excluding non-controlling interests held by third parties)
|
$
|
1,303,397
|
|
|
$
|
1,311,655
|
|
|
5.2
|
%
|
|
6.3
|
%
|
|
2.0
|
|
As of December 31, 2015
|
||||||||||||||
|
Carrying Amount (1)
|
|
Outstanding Principal (1)
|
|
Weighted Average Interest Rate
|
|
Weighted Average Unleveraged Effective Yield (2)
|
|
Weighted Average Remaining Life (Years)
|
||||||
Senior mortgage loans
|
$
|
961,395
|
|
|
$
|
965,578
|
|
|
4.4
|
%
|
|
5.1
|
%
|
|
1.4
|
Subordinated debt and preferred equity investments
|
166,417
|
|
|
168,264
|
|
|
10.6
|
%
|
|
11.2
|
%
|
|
5.1
|
||
Total loans held for investment portfolio (excluding non-controlling interests held by third parties)
|
$
|
1,127,812
|
|
|
$
|
1,133,842
|
|
|
5.3
|
%
|
|
6.0
|
%
|
|
1.9
|
(1)
|
The difference between the Carrying Amount and the Outstanding Principal face amount of the loans held for investment consists of unamortized purchase discount, deferred loan fees and loan origination costs. The tables above exclude non-controlling interests held by third parties. A reconciliation of the Carrying Amount of loans held for investment portfolio, excluding non-controlling interests held by third parties, to the Carrying Amount of loans held for investment, as included within the Company's consolidated balance sheets is presented below.
|
(2)
|
Unleveraged Effective Yield is the compounded effective rate of return that would be earned over the life of the investment based on the contractual interest rate (adjusted for any deferred loan fees, costs, premium or discount) and assumes
no
dispositions, early prepayments or defaults. The Total Weighted Average Unleveraged Effective Yield is calculated based on the average of Unleveraged Effective Yield of all loans held by the Company as of
December 31, 2016 and 2015
as weighted by the Outstanding Principal balance of each loan.
|
|
As of December 31, 2016
|
||||||
|
Carrying Amount
|
|
Outstanding Principal
|
||||
Total loans held for investment portfolio (excluding non-controlling interests held by third parties)
|
$
|
1,303,397
|
|
|
$
|
1,311,655
|
|
Non-controlling interest investment held by third parties
|
10,540
|
|
|
10,540
|
|
||
Loans held for investment
|
$
|
1,313,937
|
|
|
$
|
1,322,195
|
|
|
As of December 31, 2015
|
||||||
|
Carrying Amount
|
|
Outstanding Principal
|
||||
Total loans held for investment portfolio (excluding non-controlling interests held by third parties)
|
$
|
1,127,812
|
|
|
$
|
1,133,842
|
|
Non-controlling interest investment held by third parties
|
46,579
|
|
|
46,579
|
|
||
Loans held for investment
|
$
|
1,174,391
|
|
|
$
|
1,180,421
|
|
Loan Type
|
|
Location
|
|
Outstanding Principal (1)
|
|
Carrying Amount (1)
|
|
Interest Rate
|
|
Unleveraged Effective Yield (2)
|
|
Maturity Date (3)
|
|
Payment Terms (4)
|
|
Senior Mortgage Loans:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Various
|
(5)
|
Diversified
|
|
$159.2
|
|
$158.0
|
|
L+4.35%
|
|
6.3%
|
|
Oct 2018
|
|
I/O
|
|
Various
|
(6)
|
Diversified
|
|
98.9
|
|
98.2
|
|
L+4.75%
|
|
6.8%
|
|
Oct 2018
|
|
I/O
|
|
Multifamily
|
|
FL
|
|
89.7
|
|
89.3
|
|
L+4.75%
|
|
6.1%
|
|
Sep 2019
|
|
I/O
|
|
Retail
|
|
IL
|
|
75.9
|
|
75.8
|
|
L+4.00%
|
|
5.1%
|
|
Aug 2017
|
|
I/O
|
|
Mixed-use
|
|
NY
|
|
65.6
|
|
65.2
|
|
L+4.16%
|
|
5.4%
|
|
Apr 2019
|
|
I/O
|
|
Office
|
|
TX
|
|
63.7
|
|
63.0
|
|
L+4.30%
|
|
5.9%
|
|
Dec 2018
|
|
I/O
|
|
Office
|
|
CA
|
|
57.5
|
|
57.0
|
|
L+4.40%
|
|
5.7%
|
|
Aug 2019
|
|
I/O
|
|
Hotel
|
|
CA
|
|
56.0
|
|
55.6
|
|
L+4.75%
|
|
6.2%
|
|
Feb 2019
|
|
I/O
|
|
Office
|
|
IL
|
|
53.2
|
|
52.6
|
|
L+3.99%
|
|
5.2%
|
|
Aug 2019
|
|
I/O
|
|
Multifamily
|
|
FL
|
|
45.4
|
|
45.1
|
|
L+4.75%
|
|
6.1%
|
|
Sep 2019
|
|
I/O
|
|
Healthcare
|
|
NY
|
|
41.6
|
|
41.6
|
|
L+5.00%
|
|
6.1%
|
|
Dec 2017
|
(7)
|
I/O
|
|
Office
|
|
FL
|
|
38.4
|
|
38.4
|
|
L+3.65%
|
|
4.6%
|
|
Oct 2017
|
|
I/O
|
|
Hotel
|
|
NY
|
|
36.5
|
|
36.3
|
|
L+4.75%
|
|
6.0%
|
|
June 2018
|
|
I/O
|
|
Hotel
|
|
MI
|
|
35.2
|
|
35.2
|
|
L+4.15%
|
|
5.1%
|
|
July 2017
|
|
I/O
|
|
Multifamily
|
|
MN
|
|
34.1
|
|
33.8
|
|
L+4.75%
|
|
6.1%
|
|
Oct 2019
|
|
I/O
|
|
Industrial
|
|
OH
|
|
32.5
|
|
32.4
|
|
L+4.20%
|
|
5.3%
|
|
May 2018
|
|
I/O
|
(8)
|
Office
|
|
OR
|
|
30.6
|
|
30.5
|
|
L+3.75%
|
|
4.9%
|
|
Oct 2018
|
|
I/O
|
|
Retail
|
|
IL
|
|
30.4
|
|
30.3
|
|
L+3.25%
|
|
4.4%
|
|
Sep 2018
|
|
I/O
|
|
Multifamily
|
|
NY
|
|
29.4
|
|
29.3
|
|
L+3.75%
|
|
5.0%
|
|
Oct 2017
|
|
I/O
|
|
Multifamily
|
|
TX
|
|
24.9
|
|
24.8
|
|
L+3.80%
|
|
4.7%
|
|
Jan 2019
|
|
I/O
|
|
Multifamily
|
|
FL
|
|
20.2
|
|
20.0
|
|
L+4.25%
|
|
5.7%
|
|
Feb 2019
|
|
I/O
|
|
Office
|
|
PA
|
|
19.6
|
|
19.4
|
|
L+4.70%
|
|
6.0%
|
|
Mar 2020
|
|
I/O
|
|
Office
|
|
CO
|
|
19.5
|
|
19.4
|
|
L+3.95%
|
|
5.2%
|
|
Dec 2017
|
|
I/O
|
|
Multifamily
|
|
NY
|
|
15.3
|
|
15.3
|
|
L+3.85%
|
|
5.0%
|
|
Nov 2017
|
|
I/O
|
|
Office
|
|
CA
|
|
15.1
|
|
15.1
|
|
L+4.50%
|
|
5.4%
|
|
July 2018
|
|
I/O
|
|
Subordinated Debt and Preferred Equity Investments:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Multifamily
|
|
GA/FL
|
|
37.7
|
|
37.3
|
|
L+11.85%
|
(9)
|
12.9%
|
|
June 2021
|
|
I/O
|
|
Multifamily
|
|
NY
|
|
33.3
|
|
33.2
|
|
L+8.07%
|
|
9.1%
|
|
Jan 2019
|
|
I/O
|
|
Office
|
|
NJ
|
|
17.0
|
|
16.3
|
|
12.00%
|
|
12.8%
|
|
Jan 2026
|
|
I/O
|
(8)
|
Office
|
|
GA
|
|
14.3
|
|
14.3
|
|
9.50%
|
|
9.5%
|
|
Aug 2017
|
|
I/O
|
|
Various
|
(10)
|
Diversified
|
|
11.0
|
|
10.8
|
|
10.95%
|
|
11.7%
|
|
Dec 2024
|
|
I/O
|
|
Office
|
|
TX
|
|
10.0
|
|
9.9
|
|
14.00%
|
|
14.6%
|
|
Dec 2018
|
|
I/O
|
|
Total/Weighted Average
|
|
|
|
$1,311.7
|
|
$1,303.4
|
|
|
|
6.3%
|
|
|
|
|
|
(1)
|
The difference between the Carrying Amount and the Outstanding Principal amount of the loans held for investment consists of unamortized purchase discount, deferred loan fees and loan origination costs.
|
(2)
|
Unleveraged Effective Yield is the compounded effective rate of return that would be earned over the life of the investment based on the contractual interest rate (adjusted for any deferred loan fees, costs, premium or discount) and assumes no dispositions, early prepayments or defaults. Unleveraged Effective Yield for each loan is calculated based on LIBOR as of
December 31, 2016
or the LIBOR floor, as applicable. The Weighted Average Unleveraged Effective Yield is calculated based on the average of Unleveraged Effective Yield of all loans held by the Company as of
December 31, 2016
as weighted by the Outstanding Principal balance of each loan.
|
(3)
|
Certain loans are subject to contractual extension options that vary between
one
and
two
12-month extensions and may be subject to performance based or other conditions as stipulated in the loan agreement. Actual maturities may differ from contractual maturities stated herein as certain borrowers may have the right to prepay with or without paying a prepayment penalty. The Company may also extend contractual maturities in connection with loan modifications.
|
(4)
|
I/O = interest only, P/I = principal and interest.
|
(5)
|
The senior mortgage loan, which had an outstanding principal balance of
$159.2 million
as of
December 31, 2016
, is collateralized by a portfolio of assets comprised of self-storage, retail and office properties.
|
(6)
|
The senior mortgage loan, which had an outstanding principal balance of
$98.9 million
as of
December 31, 2016
, is collateralized by a portfolio of assets comprised of self-storage and retail properties.
|
(7)
|
In December 2016, the borrower exercised a one-year extension option in accordance with the loan agreement, which extended the maturity date on the senior New York loan to December 2017.
|
(8)
|
In May 2017, amortization will begin on the senior Ohio loan, which had an outstanding principal balance of
$32.5 million
as of
December 31, 2016
. In February 2021, amortization will begin on the subordinated New Jersey loan, which had an outstanding principal balance of
$17.0 million
as of
December 31, 2016
. The remainder of the loans in the Company’s portfolio are non-amortizing through their primary terms.
|
(9)
|
The preferred return is L+
11.85%
with
2.00%
as payment-in-kind ("PIK"), to the extent cash flow is not available. There is no capped dollar amount on accrued PIK.
|
(10)
|
The preferred equity investment is in an entity whose assets are comprised of multifamily, student housing and medical office properties.
|
Balance at December 31, 2014
|
$
|
1,462,584
|
|
Initial funding
|
159,348
|
|
|
Origination fees and discounts, net of costs
|
(1,078
|
)
|
|
Additional funding
|
70,529
|
|
|
Amortizing payments
|
(601
|
)
|
|
Loan payoffs
|
(446,745
|
)
|
|
Loans sold to third parties (1)
|
(74,625
|
)
|
|
Origination fee accretion
|
4,979
|
|
|
Balance at December 31, 2015
|
$
|
1,174,391
|
|
Initial funding
|
830,092
|
|
|
Origination fees and discounts, net of costs
|
(8,152
|
)
|
|
Additional funding
|
33,366
|
|
|
Amortizing payments
|
(463
|
)
|
|
Loan payoffs
|
(721,221
|
)
|
|
Origination fee accretion
|
5,924
|
|
|
Balance at December 31, 2016
|
$
|
1,313,937
|
|
(1)
|
In July 2015, the Company sold a loan to a third party that was previously classified as held for investment. At the time of the sale, the loan had an unleveraged effective yield of
4.2%
as compared to the
4.9%
weighted average unleveraged effective yield for all senior loans held by the Company. No gain or loss was recognized on the sale.
|
|
As of December 31,
|
|
||||||||||||||
|
2016
|
|
2015
|
|
||||||||||||
|
Outstanding Balance
|
|
Total
Commitment |
|
Outstanding Balance
|
|
Total
Commitment |
|
||||||||
Wells Fargo Facility
|
$
|
218,064
|
|
|
$
|
325,000
|
|
(1)
|
$
|
101,473
|
|
|
$
|
225,000
|
|
|
Citibank Facility
|
302,240
|
|
|
250,000
|
|
(2)
|
112,827
|
|
|
250,000
|
|
|
||||
BAML Facility
|
77,679
|
|
|
125,000
|
|
(3)
|
—
|
|
|
50,000
|
|
|
||||
March 2014 CNB Facility
|
—
|
|
|
50,000
|
|
|
—
|
|
|
50,000
|
|
|
||||
July 2014 CNB Facility
|
—
|
|
(4)
|
—
|
|
(4)
|
66,200
|
|
|
75,000
|
|
|
||||
MetLife Facility
|
53,130
|
|
|
180,000
|
|
|
109,474
|
|
|
180,000
|
|
|
||||
April 2014 UBS Facility
|
71,360
|
|
|
140,000
|
|
|
75,558
|
|
|
140,000
|
|
|
||||
December 2014 UBS Facility
|
—
|
|
(5)
|
—
|
|
(5)
|
57,243
|
|
|
57,243
|
|
|
||||
U.S. Bank Facility
|
58,240
|
|
|
125,000
|
|
(6)
|
—
|
|
|
—
|
|
|
||||
Secured Term Loan
|
155,000
|
|
|
155,000
|
|
|
75,000
|
|
|
155,000
|
|
|
||||
Total
|
$
|
935,713
|
|
|
$
|
1,350,000
|
|
|
$
|
597,775
|
|
|
$
|
1,182,243
|
|
|
(1)
|
In June 2016, the Company amended the Wells Fargo Facility (defined below) to increase the facility's commitment size from
$225.0 million
to
$325.0 million
.
|
(2)
|
In July 2016, the Company amended the Citibank Facility (defined below) to add an accordion feature that provides for an increase in the
$250.0 million
commitment amount with respect to approved assets, as determined by Citibank, N.A. in its sole discretion.
|
(3)
|
In August 2016, the Company amended and restated the existing BAML Facility (defined below) to increase the facility's commitment size from
$50.0 million
to
$125.0 million
.
|
(4)
|
The July 2014 CNB Facility (defined below) has been repaid in full and its terms were not extended.
|
(5)
|
The December 2014 UBS Facility (defined below) has been repaid in full and its terms were not extended.
|
(6)
|
In August 2016, the Company entered into a
$125.0 million
master repurchase and securities contract with U.S. Bank (defined below).
|
|
Wells Fargo
Facility |
|
Citibank
Facility |
|
BAML Facility
|
|
March 2014 CNB Facility
|
|
MetLife Facility
|
|
April 2014 UBS Facility
|
|
U.S. Bank Facility
|
|
Secured Term Loan
|
|
Total
|
||||||||||||||||||
2017
|
$
|
218,064
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
53,130
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
271,194
|
|
2018
|
—
|
|
|
302,240
|
|
|
77,679
|
|
|
—
|
|
|
—
|
|
|
71,360
|
|
|
—
|
|
|
155,000
|
|
|
606,279
|
|
|||||||||
2019
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
58,240
|
|
|
—
|
|
|
58,240
|
|
|||||||||
2020
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|||||||||
2021
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|||||||||
Thereafter
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|||||||||
|
$
|
218,064
|
|
|
$
|
302,240
|
|
|
$
|
77,679
|
|
|
$
|
—
|
|
|
$
|
53,130
|
|
|
$
|
71,360
|
|
|
$
|
58,240
|
|
|
$
|
155,000
|
|
|
$
|
935,713
|
|
|
As of December 31,
|
||||||
|
2016
|
|
2015
|
||||
Total commitments
|
$
|
1,380,805
|
|
|
$
|
1,232,163
|
|
Less: funded commitments
|
(1,311,655
|
)
|
|
(1,133,842
|
)
|
||
Total unfunded commitments
|
$
|
69,150
|
|
|
$
|
98,321
|
|
Grant Date
|
|
Vesting Start Date
|
|
Shares Granted
|
May 1, 2012
|
|
July 1, 2012
|
|
35,135
|
June 18, 2012
|
|
July 1, 2012
|
|
7,027
|
July 9, 2012
|
|
October 1, 2012
|
|
25,000
|
June 26, 2013
|
|
July 1, 2013
|
|
22,526
|
November 25, 2013
|
|
November 25, 2016
|
|
30,381
|
January 31, 2014
|
|
August 31, 2015
|
|
48,273
|
February 26, 2014
|
|
February 26, 2014
|
|
12,030
|
February 27, 2014
|
|
August 27, 2014
|
|
22,354
|
June 24, 2014
|
|
June 24, 2014
|
|
17,658
|
June 24, 2015
|
|
July 1, 2015
|
|
25,555
|
April 25, 2016
|
|
July 1, 2016
|
|
10,000
|
June 27, 2016
|
|
July 1, 2016
|
|
24,680
|
Total
|
|
|
|
280,619
|
|
Restricted Stock Grants—Directors
|
|
Restricted Stock Grants—Officer
|
|
Restricted Stock Grants—Employees
|
|
Total
|
||||
Balance at December 31, 2015
|
16,945
|
|
|
4,686
|
|
|
62,563
|
|
|
84,194
|
|
Granted
|
34,680
|
|
|
—
|
|
|
—
|
|
|
34,680
|
|
Vested
|
(28,834
|
)
|
|
(4,686
|
)
|
|
(32,182
|
)
|
|
(65,702
|
)
|
Forfeited
|
(1,277
|
)
|
|
—
|
|
|
(30,381
|
)
|
|
(31,658
|
)
|
Balance at December 31, 2016
|
21,514
|
|
|
—
|
|
|
—
|
|
|
21,514
|
|
|
Restricted Stock Grants—Directors
|
|
Restricted Stock Grants—Officer
|
|
Restricted Stock Grants—Employees
|
|
Total
|
||||
2017
|
16,510
|
|
|
—
|
|
|
—
|
|
|
16,510
|
|
2018
|
3,336
|
|
|
—
|
|
|
—
|
|
|
3,336
|
|
2019
|
1,668
|
|
|
—
|
|
|
—
|
|
|
1,668
|
|
2020
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
2021
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
Total
|
21,514
|
|
|
—
|
|
|
—
|
|
|
21,514
|
|
|
For the years ended December 31,
|
||||||||||||||||||||||||||||||||||||||||||||||
|
2016
|
|
2015
|
|
2014
|
||||||||||||||||||||||||||||||||||||||||||
|
Restricted Stock Grants
|
|
Restricted Stock Grants
|
|
Restricted Stock Grants
|
||||||||||||||||||||||||||||||||||||||||||
|
Directors
|
|
Officers
|
|
Employees
|
|
Total
|
|
Directors
|
|
Officers
|
|
Employees
|
|
Total
|
|
Directors
|
|
Officers
|
|
Employees
|
|
Total
|
||||||||||||||||||||||||
Compensation expense (1)
|
$
|
355
|
|
|
$
|
53
|
|
|
$
|
(96
|
)
|
|
$
|
312
|
|
|
$
|
330
|
|
|
$
|
106
|
|
|
$
|
399
|
|
|
$
|
835
|
|
|
$
|
445
|
|
|
$
|
106
|
|
|
$
|
388
|
|
|
$
|
939
|
|
Total fair value of shares vested (2)
|
342
|
|
|
54
|
|
|
383
|
|
|
779
|
|
|
313
|
|
|
72
|
|
|
201
|
|
|
586
|
|
|
399
|
|
|
79
|
|
|
56
|
|
|
534
|
|
||||||||||||
Weighted average grant date fair value
|
412
|
|
|
—
|
|
|
—
|
|
|
412
|
|
|
299
|
|
|
—
|
|
|
—
|
|
|
299
|
|
|
385
|
|
|
—
|
|
|
944
|
|
|
1,329
|
|
(1)
|
Compensation expense for ACRE Capital employees is included in compensation and benefits expense for the years ended December 31, 2016, 2015 and 2014 in the reconciliation of net income from operations of discontinued operations, net of income taxes. See Note
13
included in these consolidated financial statements for more information.
|
(2)
|
Based on the closing price of the Company's common stock on the NYSE on each vesting date.
|
|
For the years ended December 31,
|
||||||||||
|
2016
|
|
2015
|
|
2014
|
||||||
Net income from continuing operations, less non-controlling interests
|
$
|
25,919
|
|
|
$
|
27,300
|
|
|
$
|
22,529
|
|
Net income from discontinued operations, including gain on sale of discontinued operations
|
14,417
|
|
|
6,985
|
|
|
1,867
|
|
|||
Divided by:
|
|
|
|
|
|
|
|
|
|||
Basic weighted average shares of common stock outstanding:
|
28,461,853
|
|
|
28,501,897
|
|
|
28,459,309
|
|
|||
Non-vested restricted stock
|
61,453
|
|
|
95,671
|
|
|
125,713
|
|
|||
Diluted weighted average shares of common stock outstanding:
|
28,523,306
|
|
|
28,597,568
|
|
|
28,585,022
|
|
|||
Basic earnings per common share (1):
|
|
|
|
|
|
|
|
|
|||
Continuing operations
|
$
|
0.91
|
|
|
$
|
0.96
|
|
|
$
|
0.79
|
|
Discontinued operations
|
0.51
|
|
|
0.25
|
|
|
0.07
|
|
|||
Net income
|
$
|
1.42
|
|
|
$
|
1.20
|
|
|
$
|
0.86
|
|
Diluted earnings per common share (1):
|
|
|
|
|
|
|
|
|
|||
Continuing operations
|
$
|
0.91
|
|
|
$
|
0.95
|
|
|
$
|
0.79
|
|
Discontinued operations
|
0.51
|
|
|
0.24
|
|
|
0.07
|
|
|||
Net income
|
$
|
1.41
|
|
|
$
|
1.20
|
|
|
$
|
0.85
|
|
(1)
|
The Company has considered the impact of the 2015 Convertible Notes and the restricted shares on diluted earnings per common share. The number of shares of common stock that the 2015 Convertible Notes are convertible into were not included in the computation of diluted net income per common share because the inclusion of those shares would have been anti-dilutive for the years ended
December 31, 2015
and
2014
.
|
|
For the years ended December 31,
|
||||||||||
|
2016
|
|
2015
|
|
2014
|
||||||
Current
|
$
|
21
|
|
|
$
|
(11
|
)
|
|
$
|
240
|
|
Deferred
|
—
|
|
|
—
|
|
|
—
|
|
|||
Excise tax
|
209
|
|
|
—
|
|
|
—
|
|
|||
Total income tax expense (benefit), including
excise tax |
$
|
230
|
|
|
$
|
(11
|
)
|
|
$
|
240
|
|
•
|
Level 2-Prices are determined using other significant observable inputs. Observable inputs are inputs that other market participants would use in pricing a security. These may include quoted prices for similar securities, interest rates, prepayment speeds, credit risk and others.
|
•
|
Level 3-Prices are determined using significant unobservable inputs. In situations where quoted prices or observable inputs are unavailable (for example, when there is little or no market activity for an investment at the end of the period), unobservable inputs may be used.
|
|
|
|
As of December 31,
|
||||||||||||||
|
|
|
2016
|
|
2015
|
||||||||||||
|
Level in Fair Value Hierarchy
|
|
Carrying Value
|
|
Fair Value
|
|
Carrying Value
|
|
Fair Value
|
||||||||
Financial assets:
|
|
|
|
|
|
|
|
|
|
||||||||
Loans held for investment
|
3
|
|
$
|
1,313,937
|
|
|
$
|
1,322,195
|
|
|
$
|
1,174,391
|
|
|
$
|
1,180,421
|
|
Financial liabilities:
|
|
|
|
|
|
|
|
|
|
||||||||
Secured funding agreements
|
2
|
|
$
|
780,713
|
|
|
$
|
780,713
|
|
|
$
|
522,775
|
|
|
$
|
522,775
|
|
Secured term loan
|
2
|
|
149,878
|
|
|
155,000
|
|
|
69,762
|
|
|
75,000
|
|
||||
Commercial mortgage-backed securitization debt (consolidated VIE)
|
3
|
|
—
|
|
|
—
|
|
|
61,815
|
|
|
61,856
|
|
||||
Collateralized loan obligation securitization debt (consolidated VIE)
|
3
|
|
—
|
|
|
—
|
|
|
192,528
|
|
|
193,419
|
|
|
Incurred
|
|
Payable
|
||||||||||||||||
|
For the years ended December 31,
|
|
As of December 31,
|
||||||||||||||||
|
2016
|
|
2015
|
|
2014
|
|
2016
|
|
2015
|
||||||||||
Affiliate Payments
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
Management fees
|
$
|
5,608
|
|
|
$
|
5,397
|
|
|
$
|
5,440
|
|
|
$
|
1,549
|
|
|
$
|
1,357
|
|
Incentive fees
|
348
|
|
|
—
|
|
|
—
|
|
|
27
|
|
|
—
|
|
|||||
General and administrative expenses
|
3,441
|
|
|
3,426
|
|
|
3,400
|
|
|
1,024
|
|
|
835
|
|
|||||
Direct costs (1)
|
848
|
|
|
1,466
|
|
|
756
|
|
|
99
|
|
|
232
|
|
|||||
Total
|
$
|
10,245
|
|
|
$
|
10,289
|
|
|
$
|
9,596
|
|
|
$
|
2,699
|
|
|
$
|
2,424
|
|
Date declared
|
|
Record date
|
|
Payment date
|
|
Per share amount
|
|
Total amount
|
||||
November 3, 2016
|
|
December 30, 2016
|
|
January 17, 2017
|
|
$
|
0.26
|
|
|
$
|
7,406
|
|
August 4, 2016
|
|
September 30, 2016
|
|
October 17, 2016
|
|
0.26
|
|
|
7,406
|
|
||
May 5, 2016
|
|
June 30, 2016
|
|
July 15, 2016
|
|
0.26
|
|
|
7,413
|
|
||
March 1, 2016
|
|
March 31, 2016
|
|
April 15, 2016
|
|
0.26
|
|
|
7,429
|
|
||
Total cash dividends declared for the year ended December 31, 2016
|
|
|
|
|
|
$
|
1.04
|
|
|
$
|
29,654
|
|
November 5, 2015
|
|
December 31, 2015
|
|
January 19, 2016
|
|
$
|
0.25
|
|
|
$
|
7,152
|
|
July 30, 2015
|
|
September 30, 2015
|
|
October 15, 2015
|
|
0.25
|
|
|
7,152
|
|
||
May 7, 2015
|
|
June 30, 2015
|
|
July 15, 2015
|
|
0.25
|
|
|
7,152
|
|
||
March 5, 2015
|
|
March 31, 2015
|
|
April 15, 2015
|
|
0.25
|
|
|
7,146
|
|
||
Total cash dividends declared for the year ended December 31, 2015
|
|
|
|
|
|
$
|
1.00
|
|
|
$
|
28,602
|
|
November 10, 2014
|
|
December 31, 2014
|
|
January 15, 2015
|
|
$
|
0.25
|
|
|
$
|
7,147
|
|
August 6, 2014
|
|
September 30, 2014
|
|
October 15, 2014
|
|
0.25
|
|
|
7,151
|
|
||
May 7, 2014
|
|
June 30, 2014
|
|
July 16, 2014
|
|
0.25
|
|
|
7,151
|
|
||
March 17, 2014
|
|
March 31, 2014
|
|
April 16, 2014
|
|
0.25
|
|
|
7,147
|
|
||
Total cash dividends declared for the year ended December 31, 2014
|
|
|
|
|
|
$
|
1.00
|
|
|
$
|
28,596
|
|
|
As of December 31,
|
||||||
|
2016
|
|
2015
|
||||
Carrying value
|
$
|
37,373
|
|
|
$
|
55,144
|
|
Maximum exposure to loss
|
$
|
37,679
|
|
|
$
|
55,704
|
|
|
As of December 31,
|
||||||
|
2016
|
|
2015
|
||||
ASSETS
|
|
|
|
||||
Cash and cash equivalents
|
$
|
—
|
|
|
$
|
3,929
|
|
Restricted cash
|
—
|
|
|
17,297
|
|
||
Loans held for sale, at fair value
|
—
|
|
|
30,612
|
|
||
Mortgage servicing rights, at fair value
|
—
|
|
|
61,800
|
|
||
Other assets
|
—
|
|
|
19,613
|
|
||
Assets of discontinued operations
|
$
|
—
|
|
|
$
|
133,251
|
|
LIABILITIES
|
|
|
|
||||
Warehouse lines of credit
|
$
|
—
|
|
|
$
|
24,806
|
|
Allowance for loss sharing
|
—
|
|
|
8,969
|
|
||
Due to affiliate
|
—
|
|
|
234
|
|
||
Other liabilities
|
—
|
|
|
17,522
|
|
||
Liabilities of discontinued operations
|
$
|
—
|
|
|
$
|
51,531
|
|
|
For the years ended December 31,
|
||||||||||
|
2016
|
|
2015
|
|
2014
|
||||||
Mortgage banking revenue:
|
|
|
|
|
|
||||||
Servicing fees, net
|
$
|
11,081
|
|
|
$
|
16,051
|
|
|
$
|
16,399
|
|
Gains from mortgage banking activities
|
24,034
|
|
|
27,067
|
|
|
17,492
|
|
|||
Provision for loss sharing
|
146
|
|
|
1,093
|
|
|
1,364
|
|
|||
Change in fair value of mortgage servicing rights
|
(6,457
|
)
|
|
(8,798
|
)
|
|
(7,650
|
)
|
|||
Mortgage banking revenue
|
28,804
|
|
|
35,413
|
|
|
27,605
|
|
|||
Expenses:
|
|
|
|
|
|
|
|
|
|||
Management fees to affiliate
|
446
|
|
|
551
|
|
|
476
|
|
|||
Professional fees
|
718
|
|
|
1,073
|
|
|
1,047
|
|
|||
Compensation and benefits
|
18,108
|
|
|
20,448
|
|
|
18,649
|
|
|||
Transaction costs
|
797
|
|
|
—
|
|
|
—
|
|
|||
General and administrative expenses
|
3,049
|
|
|
3,965
|
|
|
6,249
|
|
|||
General and administrative expenses reimbursed to affiliate
|
622
|
|
|
452
|
|
|
600
|
|
|||
Total expenses
|
23,740
|
|
|
26,489
|
|
|
27,021
|
|
|||
Income from operations before income taxes
|
5,064
|
|
|
8,924
|
|
|
584
|
|
|||
Income tax expense (benefit)
|
843
|
|
|
1,939
|
|
|
(1,283
|
)
|
|||
Net income from operations of discontinued operations, net of income taxes
|
$
|
4,221
|
|
|
$
|
6,985
|
|
|
$
|
1,867
|
|
Balance at December 31, 2014
|
$
|
58,889
|
|
MSRs purchased
|
549
|
|
|
Additions, following sale of loan
|
13,267
|
|
|
Changes in fair value
|
(8,798
|
)
|
|
Prepayments and write-offs
|
(2,107
|
)
|
|
Balance at December 31, 2015 (1)
|
$
|
61,800
|
|
MSRs purchased
|
323
|
|
|
Additions, following sale of loan
|
10,275
|
|
|
Changes in fair value
|
(6,457
|
)
|
|
Prepayments and write-offs
|
(3,058
|
)
|
|
MSRs included in the ACRE Capital Sale
|
(62,883
|
)
|
|
Balance at December 31, 2016
|
$
|
—
|
|
(1)
|
MSRs are included in mortgage servicing rights at fair value as of
December 31, 2015
in the reconciliation of the carrying amounts of major classes of assets and liabilities of the discontinued operations to assets and liabilities of discontinued operations that are presented separately in the consolidated balance sheets.
|
Balance at December 31, 2014
|
$
|
12,349
|
|
Current period provision for loss sharing
|
(1,093
|
)
|
|
Settlements/Writeoffs
|
(2,287
|
)
|
|
Balance at December 31, 2015 (1)
|
$
|
8,969
|
|
Current period provision for loss sharing
|
(146
|
)
|
|
Settlements/Writeoffs
|
(788
|
)
|
|
Allowance for loss sharing included in the ACRE Capital Sale
|
(8,035
|
)
|
|
Balance at December 31, 2016
|
$
|
—
|
|
(1)
|
Allowance for loss sharing is included in allowance for loss sharing as of
December 31, 2015
in the reconciliation of the carrying amounts of major classes of assets and liabilities of the discontinued operations to assets and liabilities of discontinued operations that are presented separately in the Company's consolidated balance sheets.
|
|
|
As of December 31, 2015
|
||
Commitments to sell loans
|
|
$
|
237,372
|
|
Commitments to fund loans
|
|
$
|
207,566
|
|
|
|
As of December 31, 2015
|
||||
Derivatives not designated as hedging instruments
|
|
Balance Sheet Location
|
|
Fair Value
|
||
Loan commitments
|
|
Assets of discontinued operations
|
(1)
|
$
|
8,450
|
|
Forward sale commitments
|
|
Assets of discontinued operations
|
(1)
|
25
|
|
|
MSR purchase commitment
|
|
Assets of discontinued operations
|
(1)
|
330
|
|
|
Forward sale commitments
|
|
Liabilities of discontinued operations
|
(1)
|
(1,868
|
)
|
|
Total derivatives not designated as hedging instruments
|
|
|
|
$
|
6,937
|
|
(1)
|
Derivative financial instruments are included in other assets or other liabilities as of
December 31, 2015
in the reconciliation of the carrying amounts of major classes of assets and liabilities of the discontinued operations to assets and liabilities of discontinued operations that are presented separately in the Company's consolidated balance sheet. See above for more information.
|
|
For the years ended December 31,
|
||||||||||
|
2016
|
|
2015
|
|
2014
|
||||||
Current
|
$
|
(1,206
|
)
|
|
$
|
(154
|
)
|
|
$
|
89
|
|
Deferred
|
2,049
|
|
|
2,093
|
|
|
(1,372
|
)
|
|||
Total income tax expense
|
$
|
843
|
|
|
$
|
1,939
|
|
|
$
|
(1,283
|
)
|
|
As of December 31, 2015
|
||
Deferred tax assets
|
|
||
Mortgage servicing rights
|
$
|
4,083
|
|
Net operating loss carryforward
|
2,906
|
|
|
Other temporary differences
|
1,762
|
|
|
Sub-total-deferred tax assets
|
8,751
|
|
|
Deferred tax liabilities
|
|
|
|
Basis difference in assets from acquisition of ACRE Capital
|
(2,709
|
)
|
|
Components of gains from mortgage banking activities
|
(9,344
|
)
|
|
Amortization of intangible assets
|
(297
|
)
|
|
Sub-total-deferred tax liabilities
|
(12,350
|
)
|
|
Net deferred tax liability
|
$
|
(3,599
|
)
|
|
For the years ended December 31,
|
|||||||
|
2016
|
|
2015
|
|
2014
|
|||
Federal statutory rate
|
35.0
|
%
|
|
35.0
|
%
|
|
35.0
|
%
|
State income taxes
|
4.4
|
%
|
|
3.6
|
%
|
|
2.4
|
%
|
Federal benefit of state tax deduction
|
(1.5
|
)%
|
|
(1.3
|
)%
|
|
(0.8
|
)%
|
Effective tax rate
|
37.9
|
%
|
|
37.3
|
%
|
|
36.6
|
%
|
|
Fair Value as of December 31, 2015
|
||||||||||||||
|
Level 1
|
|
Level 2
|
|
Level 3
|
|
Total
|
||||||||
Loans held for sale
|
$
|
—
|
|
|
$
|
30,612
|
|
|
$
|
—
|
|
|
$
|
30,612
|
|
Mortgage servicing rights
|
—
|
|
|
—
|
|
|
61,800
|
|
|
61,800
|
|
||||
Derivative assets:
|
|
|
|
|
|
|
|
|
|
|
|
||||
Loan commitments
|
—
|
|
|
—
|
|
|
8,450
|
|
|
8,450
|
|
||||
Forward sale commitments
|
—
|
|
|
—
|
|
|
25
|
|
|
25
|
|
||||
MSR purchase commitment
|
—
|
|
|
—
|
|
|
330
|
|
|
330
|
|
||||
Derivative liabilities:
|
—
|
|
|
—
|
|
|
|
|
|
|
|
||||
Forward sale commitments
|
—
|
|
|
—
|
|
|
(1,868
|
)
|
|
(1,868
|
)
|
|
|
|
|
|
|
Unobservable Input
|
||||||
|
|
Fair
|
|
Primary
|
|
|
|
|
|
Weighted
|
||
Asset Category
|
|
Value
|
|
Valuation Technique
|
|
Input
|
|
Range
|
|
Average
|
||
Mortgage servicing rights
|
|
$
|
61,800
|
|
|
Discounted cash flow
|
|
Discount rate
|
|
8 - 14%
|
|
11.1%
|
Loan commitments and forward sale commitments
|
|
$
|
6,607
|
|
|
Discounted cash flow
|
|
Discount rate
|
|
8 - 12%
|
|
8.2%
|
MSR purchase commitment
|
|
$
|
330
|
|
|
Discounted cash flow
|
|
Discount rate
|
|
8%
|
|
8.0%
|
Balance at December 31, 2014
|
$
|
1,670
|
|
Settlements
|
(23,675
|
)
|
|
Realized gains (losses) recorded in net income (1)
|
22,005
|
|
|
Unrealized gains (losses) recorded in net income (1)
|
6,937
|
|
|
Balance at December 31, 2015
|
$
|
6,937
|
|
Settlements
|
(35,680
|
)
|
|
Realized gains (losses) recorded in net income (1)
|
28,743
|
|
|
Unrealized gains (losses) recorded in net income (1)
|
6,618
|
|
|
Derivative assets and liabilities included in the ACRE Capital Sale
|
(6,618
|
)
|
|
Balance at December 31, 2016
|
$
|
—
|
|
(1)
|
Realized and unrealized gains (losses) are included in gains from mortgage banking activities for the
years ended December 31, 2016 and 2015
in the reconciliation of net income from operations of discontinued operations, net of income taxes. See above for more information.
|
|
Incurred
|
|
Payable
|
||||||||||||
|
For the years ended December 31,
|
|
As of
|
||||||||||||
|
2016
|
|
2015
|
|
2014
|
|
December 31, 2015
|
||||||||
Affiliate Payments
|
|
|
|
|
|
|
|
||||||||
Management fees (1)
|
$
|
446
|
|
|
$
|
551
|
|
|
$
|
476
|
|
|
$
|
144
|
|
General and administrative expenses (1)
|
622
|
|
|
452
|
|
|
600
|
|
|
84
|
|
||||
Direct costs (1)
|
68
|
|
|
23
|
|
|
145
|
|
|
6
|
|
||||
Total
|
$
|
1,136
|
|
|
$
|
1,026
|
|
|
$
|
1,221
|
|
|
$
|
234
|
|
(1)
|
Related party costs payable are included in due to affiliate as of
December 31, 2015
in the reconciliation of the carrying amounts of major classes of assets and liabilities of the discontinued operations to assets and liabilities of discontinued operations that are presented separately in the Company's consolidated balance sheets. Management fees incurred are included in management fees to affiliate, general and administrative expenses incurred are included in general and administrative expenses reimbursed to affiliate and direct costs incurred are included in general and administrative expenses for the
years ended December 31, 2016, 2015 and 2014
in the reconciliation of net income from operations of discontinued operations, net of income taxes.
|
|
Employee Termination Costs
|
||
Balance at December 31, 2014
|
$
|
225
|
|
Accruals
|
44
|
|
|
Payments
|
(269
|
)
|
|
Balance at December 31, 2015
|
$
|
—
|
|
|
For the three month period ended,
|
||||||||||||||
|
March 31
|
|
June 30
|
|
September 30
|
|
December 31
|
||||||||
2016:
|
|
|
|
|
|
|
|
||||||||
Total revenue
|
$
|
10,225
|
|
|
$
|
10,514
|
|
|
$
|
11,758
|
|
|
$
|
12,610
|
|
Net income attributable to ACRE
|
$
|
6,425
|
|
|
$
|
9,981
|
|
|
$
|
19,741
|
|
|
$
|
8,721
|
|
Net income attributable to common stockholders
|
$
|
5,136
|
|
|
$
|
8,693
|
|
|
$
|
18,442
|
|
|
$
|
8,065
|
|
Net income per common share-Basic
|
$
|
0.18
|
|
|
$
|
0.31
|
|
|
$
|
0.65
|
|
|
$
|
0.28
|
|
Net income per common share-Diluted
|
$
|
0.18
|
|
|
$
|
0.31
|
|
|
$
|
0.65
|
|
|
$
|
0.28
|
|
2015:
|
|
|
|
|
|
|
|
||||||||
Total revenue
|
$
|
12,992
|
|
|
$
|
12,311
|
|
|
$
|
12,242
|
|
|
$
|
12,450
|
|
Net income attributable to ACRE
|
$
|
9,295
|
|
|
$
|
11,263
|
|
|
$
|
11,710
|
|
|
$
|
11,052
|
|
Net income attributable to common stockholders
|
$
|
7,062
|
|
|
$
|
8,967
|
|
|
$
|
9,379
|
|
|
$
|
8,877
|
|
Net income per common share-Basic
|
$
|
0.25
|
|
|
$
|
0.31
|
|
|
$
|
0.33
|
|
|
$
|
0.31
|
|
Net income per common share-Diluted
|
$
|
0.25
|
|
|
$
|
0.31
|
|
|
$
|
0.33
|
|
|
$
|
0.31
|
|
|
|
|
ARES COMMERCIAL REAL ESTATE CORPORATION
|
|
|
|
|
|
|
Dated:
|
March 7, 2017
|
|
By:
|
/s/ John Jardine
|
|
|
|
|
John Jardine
|
|
|
|
|
Co-Chief Executive Officer, Director and President (Principal Executive Officer)
|
|
|
|
|
|
Dated:
|
March 7, 2017
|
|
By:
|
/s/ Robert L. Rosen
|
|
|
|
|
Robert L. Rosen
|
|
|
|
|
Interim Co-Chief Executive Officer and Chairman (Principal Executive Officer)
|
|
|
|
|
|
Dated:
|
March 7, 2017
|
|
By:
|
/s/ Tae-Sik Yoon
|
|
|
|
|
Tae-Sik Yoon
|
|
|
|
|
Chief Financial Officer and Treasurer (Principal Financial and Accounting Officer)
|
By:
|
/s/ John Jardine
|
|
March 7, 2017
|
|
John Jardine
Co-Chief Executive Officer, Director and President
(Principal Executive Officer)
|
|
|
By:
|
/s/ Robert L. Rosen
|
|
March 7, 2017
|
|
Robert L. Rosen
Interim Co-Chief Executive Officer and Chairman
(Principal Executive Officer)
|
|
|
By:
|
/s/ Tae-Sik Yoon
|
|
March 7, 2017
|
|
Tae-Sik Yoon
Chief Financial Officer and Treasurer
(Principal Financial and Accounting Officer)
|
|
|
By:
|
/s/ Rand April
|
|
March 7, 2017
|
|
Rand April
Director
|
|
|
By:
|
/s/ Michael J Arougheti
|
|
March 7, 2017
|
|
Michael J Arougheti
Director
|
|
|
By:
|
/s/ Caroline E. Blakely
|
|
March 7, 2017
|
|
Caroline E. Blakely
Director
|
|
|
By:
|
/s/ William Browning
|
|
March 7, 2017
|
|
William Browning
Director
|
|
|
By:
|
/s/ John Hope Bryant
|
|
March 7, 2017
|
|
John Hope Bryant
Director
|
|
|
By:
|
/s/ James Skinner
|
|
March 7, 2017
|
|
James Skinner
Director
|
|
|
Name
|
|
Jurisdiction
|
|
ACRC Holdings LLC
|
|
Delaware
|
|
ACRC Lender LLC
|
|
Delaware
|
|
ACRC Lender C LLC
|
|
Delaware
|
|
ACRC Lender U LLC
|
|
Delaware
|
|
ACRC Lender U TRS LLC
|
|
Delaware
|
|
ACRC Lender U Mezz LLC
|
|
Delaware
|
|
ACRC Lender W LLC
|
|
Delaware
|
|
ACRC Lender W TRS LLC
|
|
Delaware
|
|
ACRC Champions Investor LLC
|
|
Delaware
|
|
ACRC Lender B LLC
|
|
Delaware
|
|
ACRC Lender ML LLC
|
|
Delaware
|
|
ACRC CP Investor LLC
|
|
Delaware
|
|
ACRC KA Investor LLC
|
|
Delaware
|
|
ACRC KA JV Investor LLC
|
|
Delaware
|
|
ACRE Commercial Mortgage 2014-FL2 Ltd.
|
|
Cayman
|
|
ACRC Mezz Holdings LLC
|
|
Delaware
|
|
ACRC Warehouse Holdings LLC
|
|
Delaware
|
|
ACRC Lender US LLC
|
|
Delaware
|
|
(2)
|
Registration Statement (Form S‑8 No. 333‑181077) pertaining to the Ares Commercial Real Estate Corporation 2012 Equity Incentive Plan
|
1.
|
I have reviewed this Annual Report on Form
10-K
of Ares Commercial Real Estate Corporation;
|
2.
|
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
|
3.
|
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
|
4.
|
The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
|
(a)
|
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
|
(b)
|
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
|
(c)
|
Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
|
(d)
|
Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and
|
5.
|
The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):
|
(a)
|
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
|
(b)
|
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.
|
/s/ John Jardine
|
|
John Jardine
Co-Chief Executive Officer, Director and President
|
|
1.
|
I have reviewed this Annual Report on Form
10-K
of Ares Commercial Real Estate Corporation;
|
2.
|
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
|
3.
|
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
|
4.
|
The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
|
(a)
|
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
|
(b)
|
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
|
(c)
|
Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
|
(d)
|
Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and
|
5.
|
The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):
|
(a)
|
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
|
(b)
|
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.
|
/s/ Robert L. Rosen
|
|
Robert L. Rosen
Interim Co-Chief Executive Officer and Chairman
|
|
1.
|
I have reviewed this Annual Report on Form
10-K
of Ares Commercial Real Estate Corporation;
|
2.
|
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
|
3.
|
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
|
4.
|
The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
|
(a)
|
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
|
(b)
|
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
|
(c)
|
Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
|
(d)
|
Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and
|
5.
|
The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):
|
(a)
|
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
|
(b)
|
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.
|
/s/ Tae-Sik Yoon
|
|
Tae-Sik Yoon
Chief Financial Officer and Treasurer
|
|
1.
|
The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
|
2.
|
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
|
/s/ John Jardine
|
|
John Jardine
Co-Chief Executive Officer, Director and President
|
|
|
|
/s/ Robert L. Rosen
|
|
Robert L. Rosen
Interim Co-Chief Executive Officer and Chairman
|
|
|
|
/s/ Tae-Sik Yoon
|
|
Tae-Sik Yoon
Chief Financial Officer and Treasurer
|
|